How many investments has New Enterprise Associates (NEA) made?

New Enterprise Associates (NEA) has 1,155 tracked investments, 160 of which have exited, including 97 dated in the last 24 months.

What stage does New Enterprise Associates (NEA) invest at?

New Enterprise Associates (NEA) invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What is New Enterprise Associates (NEA)'s typical check size?

New Enterprise Associates (NEA) typically writes checks of $200K – $40M.

Where is New Enterprise Associates (NEA) located?

New Enterprise Associates (NEA) is headquartered in Menlo Park, US.

Does New Enterprise Associates (NEA) lead rounds?

Yes, New Enterprise Associates (NEA) leads investment rounds.

Who does New Enterprise Associates (NEA) co-invest with?

New Enterprise Associates (NEA) most often shares deals with Andreessen Horowitz, Alumni Ventures, Kleiner Perkins, among 1,480 tracked co-investors.

New Enterprise Associates (NEA)

Venture capitalActively deploying

Menlo Park · Seed–Late Stage · 76 people tracked

Also known as NEA · Nea Management Company, Llc · New Enterprise Associates

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into New Enterprise Associates (NEA)

Each arrow is one introduction. Sign up to fill in the first one.

1,994 people can intro you to Aaron

Ask Dan Magy to introduce you to Aaron Jacobson

You →Dan · together at Firestorm →Aaron

1,015 people can intro you to Ali

Ask Jamie Chen to introduce you to Ali Behbahani

You →Jamie · together at Genocea Biosciences →Ali

1,003 people can intro you to Rick

Ask Sam Okafor to introduce you to Rick Yang

You →Sam · together at Plaid →Rick

Melissa Taunton681 people can intro you
Scott Gottlieb504 people can intro you
Blake Wu402 people can intro you

Your email: who you already know at New Enterprise Associates (NEA), and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the New Enterprise Associates (NEA) team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict

Investment thesis

NEA views venture investment as an enduring commitment to the people executing on innovative ideas rather than a transactional financial engagement. The firm partners with founders to support the realization of transformative concepts.

Invests inAI & Machine Learning Biotech Consumer Digital Health Enterprise Software HealthtechSector AgnosticChina Europe India Menlo Park Norway United Kingdom United States

Source: firm website, verified Sep 29, 2026.

Leave your own feedback

Stage

Seed–Late Stage

Check

$200K – $40M

Menlo Park, CA, US

Leads rounds

Leads

Instruments

Equity

Founded

1977

Last 12 months

59 investments

AUM

$35.6B

Tracked investments

1155

Unicorns

IPOs

Acquisitions

Team · 76 people

from the firm's website & curated & public directories

Suzanne King· Special Partner, LP Relations· United Statesin

Suzanne King is a Kauffman Fellow, a member of Class 1 of the two-year venture capital leadership program run by Kauffman Fellows. The program's member directory lists them at New Enterprise Associates in United States.

Alex Sharata· Partner· Miami, Floridain 𝕏

Alex Sharata is an investor at New Enterprise Associates who joined the firm in 2020 to lead its growth-stage investing practice across enterprise, fintech, and consumer sectors. Previously, he was an investor at Vista Equity Partners focused on majority investments in enterprise software and co-founded Fractal, a mobile app security company that was acquired in 2017. He holds a B.S. in computer science and economics from Johns Hopkins University.

Andrew Schoen· Partner· Denver, Coloradoin 𝕏

Andrew Schoen is a Partner on NEA's Technology Investing Team, where he has worked since 2014. Before joining NEA, he was part of Blackstone's M&A team and co-founded Flicstart, which was acquired. He holds a master's degree as a Schwarzman Scholar and a bachelor's degree in economics and engineering from Cornell University.

Arjun Jain· Partner· New York, New York, United Statesin

Arjun Jain is a Partner on the technology team at NEA, which he joined in 2021, focusing on consumer and enterprise investments as well as portfolio management. Before NEA, he was a merchant banker at The Raine Group in New York, working on M&A and growth equity deals across technology, media, and entertainment, and earlier worked in Sales & Trading at J.P. Morgan. He holds a BA in economics from Princeton University.

Danielle Lay· Partner· Bay Areain 𝕏

Danielle Lay is a Partner on NEA's Technology Investing Team, investing from seed to growth in generational companies focused on AI applications and physical AI. Before joining NEA in 2017, she worked as an investment banker at Goldman Sachs. She holds a BA in Economics, Business Institutions and Chinese from Northwestern University.

Forest Baskett· Special Partner· San Francisco, Californiain

Forest Baskett, a systems‑level technologist, co‑designed the Sun workstation with Andy Bechtolsheim, built a RISC at DEC that beat the VAX, served as SGI CTO, and retains founder ties.

Lila Tretikov· Partner, Head of AI Strategy· United Statesin 𝕏

Lila Tretikov is a Partner and Head of AI Strategy at NEA, investing across multiple stages, sectors, and geographies. Previously, she served as Deputy CTO at Microsoft leading AI transformation initiatives, and held executive roles including SVP at Engie and CEO of Terrawatt, where she oversaw the company's pivot toward new energy sources. She also served as CEO of Wikimedia Foundation, where she established the Wikipedia Endowment and developed the organization's AI strategy.

Luke Pappas· Partner· San Francisco Bay Areain 𝕏

Luke Pappas is a Partner on NEA's Technology team focused on consumer and enterprise investing. Previously, he worked in Technology Investment Banking at Morgan Stanley. He holds dual BS degrees in computer science and management science & engineering from Stanford University.

Mustafa Neemuchwala· Partner· Dallas suburbs, Texasin

Mustafa is a Partner on NEA's Technology Investing Team, focusing on investments from seed to late-stage growth in AI, cybersecurity, infrastructure, defense, and frontier technologies. Before joining NEA in 2021, he advised on approximately $58 billion in technology M&A transactions at Qatalyst Partners, with expertise spanning frontier tech, infrastructure, application software, cybersecurity, fintech, and consumer internet. He holds degrees from the University of Texas at Austin in finance, liberal arts, computer science, and mathematics.

Patrick Kerins· Special Partner· Marylandin

Patrick Kerins is a Special Partner at New Enterprise Associates focused on enterprise software, digital media, and growth-stage companies. He holds an MBA from Harvard Business School and has experience in venture capital investing.

Philip Chopin· Managing Director, Head of Europe· Londonin 𝕏

Philip Chopin is Managing Director and Head of Europe at NEA, which he joined in 2022 to open the firm's first European office in London. Before NEA, he was a Partner at 83North and earlier worked as a Project Leader at BCG. He holds an MBA from Kellogg and an MSc from Grenoble Ecole de Management.

Tiffany Luck· Partner· San Francisco Bay Areain 𝕏

Tiffany Luck is a Partner at New Enterprise Associates focused on early-stage AI, APIs, and B2B SaaS investments. Previously, she was a Partner at GGV Capital where she led investments in companies including Pinwheel, Mindee, Stream, Electric.ai, Fairmarkit, Workboard, and Vic.ai. Her background includes roles in marketing and business development at Forbes, Lot18, and Amazon, as well as technology investment banking at Morgan Stanley advising clients such as Github, Netflix, and Zoom.

Aaron Jacobson· Partner· San Francisco, Californiain 𝕏

Aaron Jacobson joined NEA in 2011 and works with founders in AI, cybersecurity, developer tools, and robotics. Before NEA, he spent two years in M&A advisory at Qatalyst Partners in San Francisco. He graduated summa cum laude from the Jerome Fisher Program in Management & Technology at the University of Pennsylvania with dual B.S. degrees in economics and electrical engineering and a minor in math.

ajacobson@nea.com

Ali Behbahani· Partner, co-head of healthcare team· Menlo Park, CAin

Ali Behbahani is a Partner at NEA, which he joined in 2007, and co-heads the firm's healthcare team with a focus on biopharmaceuticals and medical devices. He previously worked at The Medicines Company, Morgan Stanley, and Lehman Brothers, and conducted research at the National Institutes of Health and Duke University. He holds an MD from the University of Pennsylvania School of Medicine, an MBA from The Wharton School, and undergraduate degrees in biomedical engineering, electrical engineering, and chemistry from Duke University.

abehbahani@nea.com

Blake Wu· Partner· Menlo Park, Californiain

Blake Wu joined NEA in 2014 and invests in digital health, including healthcare services and healthcare IT, as well as biopharmaceuticals. He previously worked in the private equity group at Ares Management focused on healthcare, and earlier held roles in investment banking at Moelis & Company and equity research at Barclays Capital. He holds a BS in economics from The Wharton School at the University of Pennsylvania.

bwu@nea.com

Carmen Chang· Special Partner· Menlo Park, Californiain

Carmen Chang joined NEA in 2012 as a Special Partner and previously led the firm's Asia practice, building its presence in China and other emerging Asian markets while also working on US and European investments. Before NEA, she was a partner at a Silicon Valley law firm, specializing in corporate and securities law and leading its China practice. She holds a JD from Stanford Law School.

cchang@nea.com

Edward Mathers· Partner· Marylandin

Ed Mathers is a Partner on NEA's healthcare team, where he has worked since 2008, focusing on biotechnology and specialty pharmaceuticals investments. Before NEA, he was EVP of Corporate Development and Venture at MedImmune, contributing to its 2007 sale to AstraZeneca, and previously held roles at Inhale Therapeutic Systems and Glaxo Wellcome (now GSK). His investment interests include gene therapy, nonviral gene therapy, RNA editing, and immunology and inflammation.

emathers@nea.com

Paul Walker· Partner and Co-Head of Healthcare, NEA

Paul Walker leverages 25+ years in public biotech markets, biochemistry training and a CFA, focusing on later-stage/public/crossover biotech as a contrarian, patient multi-year partner to public companies recovering from setbacks.

pwalker@nea.com

Rick Yang· Partner, Head of Technology· San Francisco, Californiain 𝕏

Rick Yang grew up in one firm over nearly two decades, focusing on consumer behavior and financial infrastructure and championing consumer-grade experiences in opaque markets like healthcare.

ryang@nea.com

Scott Gottlieb· Partner· Chevy Chase, Marylandin 𝕏

Scott Gottlieb is a physician and policy expert who joined NEA's healthcare investment team as a Special Partner in 2019, having previously been a Venture Partner at the firm from 2007 to 2017. Between those roles he served as the 23rd Commissioner of the U.S. Food and Drug Administration (2017–2019), and earlier held positions as FDA Deputy Commissioner and Senior Adviser at the Centers for Medicare and Medicaid Services. He was a practicing hospitalist and Clinical Assistant Professor at NYU School of Medicine, is a graduate of Mount Sinai School of Medicine and Wesleyan University, and at NEA focuses on healthcare investing with an emphasis on biopharma and healthcare services.

pwalker@nea.com

Melissa Taunton· Partner· San Francisco Bay Areain

Partner at NEA.

Ali Behbahani, MD· Partner, Co-Head of Healthcare

Forest Baskett, PhD· Special Partner

Michele Park, PhD· Partner

Scott Gottlieb, MD· Partner

Ayush Goradia· Principal· New York, New York, United Statesin

Hui Cheng· Principal· San Francisco Bay Areain

Hui Cheng is a Principal at New Enterprise Associates focusing on digital health investing across all stages. She previously served as Vice President at Town Hall Ventures, where she led early to mid-stage healthcare services investments. She began her career at Bain & Company in the healthcare and private equity practice and held business operations roles at an early-stage software startup. She holds a BA in Government from Dartmouth College.

Hunter Worland· Principal· New York, New York, United Statesin

J.C. Lopez· Principal· San Francisco Bay Areain

James Buxton· Principal· New York, New York, United Statesin

James Buxton is a Principal on NEA's Healthcare team focused on life sciences investing. He trained as a cardiothoracic surgeon before transitioning to venture capital, having previously worked at SR One Capital Management, Morgan Stanley, and New Rhein Healthcare Investors. He holds a BSc and MD from University College London and an MBA from The Wharton School.

Lulu Xu· Principalin

Mason Murray· Principal· New York, New York, United Statesin

Mason Murray is a Principal on NEA's Technology team, which he joined in 2022, where he invests in consumer and enterprise companies. Before NEA, he worked on M&A, equity, and debt transactions in Bank of America's Technology, Media & Telecom investment banking group. He holds BA degrees in business management and art history from Columbia University.

Michael Li· Principal· New York, New Yorkin

Tiffany Le· Principal· San Francisco, Californiain 𝕏

Tiffany Le is a Principal at New Enterprise Associates (NEA), a venture capital firm.

J.C. Lopez, MD· Principal

James Buxton, MD· Principal

Brooke Seawell· Venture Partner· Bethesda, Marylandin

Brooke joined NEA in 2005 as a Venture Partner with expertise in software, systems, and internet investments. He brings over 40 years of experience in technology finance and operations, with a 25-year background as an operating executive at technology companies, having taken three public and sold one to Sun Microsystems. At NEA, he leverages his founding and operating experience to mentor portfolio company operators and serves on the boards of NVIDIA, Tenable, and GoodLeap.

Greg Papadopoulos· Venture Partner· San Francisco Bay Areain

Greg joined NEA as Venture Partner in 2010 and focuses on early-stage systems, software, and deep/hard-tech companies. Previously he served as EVP and CTO at Sun Microsystems and was an Associate Professor of EECS at MIT. Earlier in his career, he held engineering positions at HP and Honeywell, and co-founded companies in video conferencing, AI accelerators, portable PCs, and computational fluid dynamics.

Hilarie Koplow-McAdams· Venture Partner· Menlo Park, Californiain 𝕏

Hilarie is a Venture Partner at NEA focused on enterprise software and services. She spent three decades in operating and board roles at growth-stage software companies, including serving as President at New Relic and President of Worldwide Sales at Salesforce. She began her career at Oracle and Intuit, and holds a master's degree in public policy from the University of Chicago and a bachelor's degree from Mills College.

Jeff Immelt· Venture Partner· Menlo Park, Californiain 𝕏

Jeff Immelt is a Venture Partner at NEA who previously served as Chairman and CEO of GE for 16 years, where he led strategic and organizational transformation. He brings experience in business leadership across diverse industries and focuses on healthcare, industrial automation, clean tech, and IoT investments. Immelt holds a BA in applied mathematics from Dartmouth College and an MBA from Harvard University.

Kavita Patel· Venture Advisor, Healthcare Team· Washington, District of Columbiain 𝕏

Kavita Patel is a Venture Advisor on NEA's Healthcare team, joining the firm in 2017. She holds an MD from the University of Texas Health Science Center and an MS in health services research from UCLA, and has experience as both a practicing physician and researcher. Previously she served in the Obama Administration as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement, and currently serves as a Nonresident Fellow at The Brookings Institution.

Mark Hawkins· Venture Partner· United Statesin 𝕏

Mark Hawkins is a Venture Partner at NEA focused on technology investments, joining the firm in 2023. He previously served as President and CFO of Salesforce and held executive financial roles at Autodesk, Logitech, Dell, and HP. He holds a BA in operations management from Michigan State University, an MBA from the University of Colorado, and completed the Advanced Management Program at Harvard Business School.

Michele Park· Venture Partnerin

Michele Park is an investor at New Enterprise Associates focused on the biopharma sector. She previously held investor roles at Clarus Ventures (now Blackstone Life Sciences) and worked as a biotechnology research analyst at Credit Suisse and Piper Jaffray. She holds a PhD in molecular biology from Weill Cornell Graduate School of Medical Sciences, where she completed her dissertation at Memorial Sloan Kettering Cancer Center, and a BA in molecular biology from Princeton.

Greg Papadopoulos, PhD· Venture Partner

Scott Sandell· Executive Chairman & Chief Investment Officer· Palm Beach, FLin 𝕏

Scott Sandell joined NEA in 1996, became managing general partner in 2016, and now serves as the firm's executive chairman and chief investment officer. His investments span Salesforce, Workday, Tableau and Robinhood, with Cloudflare — where he is lead independent director — standing out as his defining deal. A Dartmouth and Stanford GSB graduate, he is also a public advocate for employing people with disabilities, drawing on his own experience with dyslexia.

ssandell@nea.com

Anna Golynskaya· Partner, Head of Capital Formation and LP Relations

Ashley Mitchell· Director, Marketing

Brad Thawley· Partner, LP Relations

Darcy Casarella· VP of Talent

Elie de Fressenel· Associatein

Emily Baine· VP of Talent

Erica Sunkin· Director, Communications

Grace Carlson· Senior Associate, LP Relations

Jennifer Ball· Director, LP Relations

Kate Barrett· Partner, Head of Communications & Marketing

Michelle Wherley· Director, LP Operations

Nick Kline· Partner, LP Relations

Ron Kosar· Chief Financial Officer, Partnership Finance

Sachin Shah· Associate, Capital Formation & LP Relations

Sam Cohen· Chief Financial Officer, Corporate Finance and Tax

Shanna Hendriks· Director, Business Development

Stephanie Brecher· Chief Legal Officer

Tracy Howe· Director, LP Relations, ESG & Events

Alexa Grabelle· Associate· New York, New York, United Statesin

Claudia Fan Munce· Venture Advisor

Danielle Ezratty· Senior Associate· New York, New York, United Statesin

Danielle Ezratty joined NEA in 2023 to focus on digital health investments. She previously worked at Clayton, Dubilier & Rice on its healthcare team conducting growth and buyout investing in healthcare services. Before that, she spent time at Morgan Stanley's Investment Banking division advising on M&A transactions in natural resources and global industrials. She holds a BS in economics with a finance concentration from Duke University, where she graduated Phi Beta Kappa, summa cum laude.

Kevin Deng· Associate· Not specifiedin

Kevin joined NEA in 2024 as an Associate on the Healthcare Investing Team, investing across all stages. He previously worked in the Healthcare Investment Banking group at Goldman Sachs, focusing on M&A and capital markets advisory for biopharma and healthcare services companies. He holds a BA in Computational Biology and a BS in Economics from the University of Pennsylvania, where he graduated summa cum laude.

Madison Faulkner· Venture Advisorin

Neehaar Gandhi· Associate· Not specified on pagein

Neehaar Gandhi is an investor at NEA focused on growth-stage investments in the technology sector. He previously worked at Fifth Wall and The Raine Group, supporting companies across physical world and media/tech/telecom ecosystems respectively. He graduated from Yale University with dual degrees in Statistics & Data Science and Environmental Studies.

Perry Wallack· Associate· San Francisco, California, United Statesin

Ryan Psik· Associate· San Francisco, California, United Statesin

Thomas Joshi· Associatein

Mohamad Makhzoumi· Co-CEO· USin

Mohamad Makhzoumi joined NEA in 2000 and serves as Co-CEO, previously Co-President and Managing General Partner of Healthcare, leading the firm's global healthcare investing across digital health and life sciences from early venture to late-stage growth. He is also a board member of the Lucile Packard Foundation for Children's Health at Stanford.

mmakhzoumi@nea.com

Tony Florence· Co-CEO· New York, New Yorkin 𝕏

Tony Florence is a hands-on, long-term board partner and trusted mentor who uses his former head-of-tech experience and Co-CEO leadership to support brand-driven, digital-commerce breakouts like Casper and Goop.

tflorence@nea.com

Kavita Patel, MD· Venture Advisor

Michael Li· Principal· Antwerp Metropolitan Areain

Joined Monogram in 2019, working on consumer and retail investments. Previously at Castanea Partners and Nomura Securities. Holds a B.S. from The Wharton School at the University of Pennsylvania.

mli@monogramcapital.com

Founder mafia

The New Enterprise Associates (NEA) mafia →

17 people who came through New Enterprise Associates (NEA) went on to found or lead other companies.

Sujay JaswaPrincipalFounded Superunlimited +2 Paul PalmieriVenture AdvisorFounded Incremental +1 Sheila Lirio MarceloVenture PartnerFounded Ohai +1 David PaffenholzInternFounded Moonfare +1 Matt SacksPrincipalFounded Luminary Media Pete SonsiniGeneral Partner, NEAFounded Instabase Tak CheungPartnerFounded Lexington Medical, Inc Arjun AggarwalVenture Capital AssociateFounded Mandrel Abheek BasuNEA Product ResidentFounded Laudspeaker Shanelle RomanVenture FellowFounded Indexical Lucious McDaniel IVVenture FellowFounded BiteSight Matthew YekellVenture Growth Equity FellowFounded Incandor

+ 5 more →

What they invest in

from 774 of 1155 portfolio companies

AI & Machine Learning ×269SaaS ×210Enterprise Software ×205Healthtech ×187Biotech ×153Data & Infrastructure ×86Consumer ×81Developer Tools ×78

HQs:United States×582United Kingdom×13China×10India×10Canada×7Japan×7

Who they back

founder profiles across 413 portfolio companies

42%

solo founders

173 of 413 mapped founding teams

44%

repeat founders

of 508 founders with career history

~3 yrs

old at investment

median across 242 dated deals

Founding team size:solo founder×1732 founders×1423 founders×624+ founders×36

Where their founders studiedfrom 479 founders with education data

Stanford University ×38University of California, Berkeley ×32Massachusetts Institute of Technology ×23Stanford University Graduate School of Business ×18Harvard Business School ×17Cornell ×14Duke University ×13University of Oxford ×13

What their founders studiedfrom 454 founders with field-of-study data

Computer Science ×173Engineering ×113Business & Management ×61Economics ×38Finance & Accounting ×28Mathematics & Statistics ×26Life Sciences ×23Physics ×22

Where their founders worked beforefrom 508 founders with career history

Google ×46Microsoft ×30Stanford University ×25IBM ×10Workday ×8Goldman Sachs ×7McKinsey & Company ×7Meta ×7

Accelerator rootsportfolio companies that came through a program

Y Combinator ×25 Techstars ×10 500 Global ×3

90 founders hold a PhD · 73 hold an MBA (of 494 with degree data) · backed the same founder in 2+ companies: 7 founders

Investments · 1,155 tracked

founders shown can be your intro path

By year:2026 · 44 2025 · 50 2024 · 24 2023 · 31 2022 · 62 2021 · 38 2020 · 24 2019 · 39 2018 · 39 2017 · 36 2016 · 29 2015 · 38524 dated

Monte Rosa Therapeuticsmonterosatx.com in 𝕏NASDAQ: GLUESep 2020✓ verified

Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.

AI & Machine LearningBiotechDeep TechHealthtechBoston, US

Markus Warmuth(M.D., Chief Executive Officer)in Sharon Townson(Ph.D., Chief Scientific Officer)in John Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)in Phil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMagnus Walter(DPhil, Chief Technology Officer)in

Board seat Ali Behbahani· per SEC Form D

Co-investorsAisling Capital HBM Partners Versant Ventures Amzak Health Avoro Capital Advisors GV (Google Ventures)+2 more

BuzzFeedbuzzfeed.com 𝕏NASDAQ: BZFDSeries C · Feb 2015 · $16M

BuzzFeed is a digital media company that produces entertainment, news, and content across pop culture, food, and commerce for online audiences.

ConsumerCreator EconomyMedia & EntertainmentNew York, US

Jonah Peretti(Director and President of AI)inJohn Johnson III(Director)Mark Frackt(Executive Officer)Greg Coleman(Executive Officer, Director)Allison Lucas(Executive Officer)JON STEINBERG(President and Chief Operating Officer)in

Board seat Patrick Kerins· per SEC Form D

Co-investorsAndreessen Horowitz Lerer Hippeau Velvet Sea Ventures Kima Ventures Macro Ventures RRE Ventures +1 more

Courseracoursera.org in 𝕏NYSE: COURJul 2020

Coursera is an online learning platform offering courses, certificates, and career programs from universities and companies such as Google.

EdTechEnterprise SoftwareFuture of WorkMarketplacesSaaSMountain View, US

Daphne Koller(Co-founder)in Andrew Ng(Co-founder)in Richard Levin(Chief Executive Officer)

Board Dan Avida(Director)John Doerr(Director)in

Board seat Scott Sandell· per SEC Form D

Co-investorsAlign Ventures Allied Venture Partners Alpha Partners Felicis Ventures G Squared GSV Ventures +14 more

CVRxcvrx.com in 𝕏NASDAQ: CVRXMay 2016

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

Craig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)Kevin Hykes(President, Chief Executive Officer & Director)in

Board seat Ali Behbahani· per SEC Form D

Co-investorsABS Ventures Treo Ventures, Llc Windham Capital Partners Ysios Capital Action Potential Venture Capital Ltd.Hatteras Venture Partners +1 more

Mirum Pharmaceuticalsmirumpharma.com in 𝕏NASDAQ: MIRMNov 2018

Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.

BiotechHealthtechSan Diego, US

Chris Peetz(Co-founder & Chief Executive Officer)in Eric Bjerkholt(Executive Officer)in Peter Radovich(Executive Officer)in

Board Patrick Heron(Director)inMichael Grey(Director)Timothy Walbert(Director)

Board seatEdward T. Mathers Edward Mathers· per SEC Form D

Co-investorsChiesi Ventures Frazier Life Sciences Longitude Capital MESA VERDE VENTURE PARTNERS Pappas Capital RiverVest Venture Partners +4 more

NextNav HoldingsNASDAQ: NNSep 2016SEC filingmedium confidence

NextNav Holdings develops ground-based positioning, navigation, and timing systems designed to complement and back up GPS using low-band spectrum assets, serving wireless carriers, government agencies, and public safety applications including enhanced 911 services.

Mclean, US

Ganesh Pattabiraman(Executive Officer, Director)Eric Swank(Chief Financial Officer)Gary Parsons(Executive Officer, Director)Mariam Sorond(President and Chief Executive Officer and Chair of the Board of Directors)

Board Bandel Carano(Director)inMatt Skaruppa(Director)

Board seatPeter Barris· per SEC Form D · $35M raise · filed Sep 2016

Co-investorsOak Investment Partners

Nkarta, Inc.nkartatx.com inNASDAQ: NKTXAug 2019

Nkarta is a biotech company developing allogeneic CAR NK cell therapies for autoimmune diseases, aiming to offer safer and more accessible alternatives to autologous CAR-T treatments.

BiotechHealthtechSouth San Francisco, US

Paul Hastings(Executive Officer, Director)inPaul H.inMatthew Plunkett(Executive Officer)inPaul J. Hastings(Chief Executive Officer)in

BoardMichael Dybbs(Director)Jill Carroll(Director)in

Board seat Ali Behbahani· per SEC Form D

Co-investorsRA Capital Samsara BioCapital SR One Capital Management Amgen Ventures Logos Norwest Venture Partners +1 more

Onkure Therapeutics Inconkuretherapeutics.com in 𝕏NASDAQ: OKUROct 2024

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies.

BiotechDigital HealthHealthtechMedical DevicesBoulder, US

Jason Leverone(Executive Officer)inSamuel Agresta(Executive Officer)in Dylan Hartley(Executive Officer)inWendy Johnson(Executive Officer)Nicholas A. Saccomano(President and Chief Executive Officer and Director)

BoardIsaac Manke(Director)in

Board seatEdward T. Mathers· per SEC Form D

Co-investorsAccess Biotechnology Boulder Ventures RiverVest Venture Partners Abingworth ACORN BIOVENTURES Novo Holdings

Robinhoodrobinhood.com in 𝕏NASDAQ: HOODOct 2020

Robinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets.

FintechMenlo Park, US

Vlad Tenev(Co-founder, Chairman and CEO)in Baiju Bhatt(Co-founder)inJason Warnick(Chief Financial Officer)in Gretchen Howard(Executive Officer)in

Board Jan Hammer(Director)in

Board seat Scott Sandell· per SEC Form D

Co-investors1/1 Capital ACME Capital Alger Aliya Capital Partners Amplo Ventures Andreessen Horowitz +60 more

Senti Biosciencessentibio.com in 𝕏NASDAQ: SNTIFeb 2018

Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.

BiotechDeep TechMedical DevicesSouth San Francisco, US

Tim Lu(Co-Founder and Chief Executive Officer)in Philip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)

BoardDonald Tang(Director)

Board seat Edward Mathers· per SEC Form D

Co-investorsEvolution VC Partners Flucas Ventures Lifeforce Capital LifeSci Venture Partners Lux Capital Menlo Ventures +12 more

Sprout Socialsproutsocial.com in 𝕏NASDAQ: SPTDec 2018 · $40.5M

Sprout Social offers a social media management platform with AI, automation, integrations and analytics tools for marketing teams.

AI & Machine LearningMarketing TechSaaSSocialChicago, US

Aaron Rankin(Executive Officer, Director)in Justyn Howard(Executive Officer, Director)in Peter Soung(Founder)in

BoardEric Lefkofksy(Director)Jason Kreuziger(Director)

Board seatPeter Barris· per SEC Form D

Co-investorsLightbank Goldman Sachs

Spyglass Pharmaspyglasspharma.com inNASDAQ: SGPMay 2025

SpyGlass Pharma develops a sustained drug delivery platform for treating chronic ophthalmic diseases such as glaucoma, integrating drugs, procedures, and devices for long-term disease control and vision preservation.

BiotechHealthtechMedical DevicesAliso Viejo, US

Glenn Sussman(Co-founder)in Malik Y. Kahook(Co-founder)inPatrick Mooney(CEO)

Board Jake Merrill(Director)Geoff Pardo(Director)Bilal Khan(Director)

Board seat Ali Behbahani· per SEC Form D

Co-investorsRA Capital Samsara BioCapital Sands Capital Ventures Vensana Capital

Synlogicsynlogictx.com in 𝕏OTC: SYBXFeb 2016

Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.

BiotechDeep TechMedical DevicesCambridge, US

Bharatt Chowrira(Executive Officer)inMichael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)in Paul Miller(Executive Officer)inAoife Brennan(Executive Officer)inTodd Shegog(Executive Officer)in

Board seat Edward Mathers· per SEC Form D

Co-investorsAtlas Venture CLI Ventures NSG Ventures Pfizer Venture Investments Sofinnova Ventures Solasta Ventures +1 more

Tempustempus.comNASDAQ: TEMOct 2022

Tempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas.

Chicago, US

Eric Lefkofsky(Founder)inErik Phelps(Executive Officer)Ryan Fukushima(Executive Officer)in

BoardBrad Keywell(Director)

Board seat Scott GottliebPeter Barris· per SEC Form D

Co-investorsCaesar Ventures Compound FPV Khosla Ventures Lightbank Lingotto +4 more

Twiliotwilio.com in 𝕏NYSE: TWLOJul 2021SEC filingmedium confidence

Twilio provides a cloud-based communications platform that enables businesses to integrate voice, messaging, and video into applications using APIs.

Cloud ComputingDeveloper ToolsEnterprise SoftwareSan Francisco, US

Jeff Lawson(Co-Founder & Chief Executive Officer)inEvan Cooke(Co-founder)John Wolthuis(Co-founder)inLee Kirkpatrick(Chief Financial Officer)in Roy Ng(Executive Officer)in Karyn Smith(Executive Officer)in

Board seat Jeff Immelt· per SEC Form D · $378.2M raise · filed Jul 2021

Co-investors500 Global Bessemer Venture Partners Craft Ventures Draper Associates Founders Circle Capital Founders Fund +19 more

Actelis Networksactelis.com in 𝕏OTC: ASNSFeb 2005 · $23M

Actelis provides hybrid-fiber networking equipment that delivers Gigabit, fiber-grade connectivity over combinations of new fiber and existing copper and coaxial lines, avoiding new construction.

CybersecurityHardwareIoTFremont, US

Tuvia Barlev(Executive Officer, Director)inEyal Aharon(Executive Officer)in Hemi Kabir(Executive Officer)in Yaron Altit(Executive Officer)in Bret Harrison(Executive Officer)in Elad Domanovitz(Executive Officer)in

Co-investorsSaints Capital Adams Street Partners Walden International

Adaptimmuneadaptimmune.com in 𝕏OTC: ADAPYSep 2014

Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.

BiotechHealthtechMedical DevicesAbingdon, Oxfordshire, US

James Noble(Chief Executive Officer)Adrian Rawcliffe(Chief Executive Officer and Director)in Gavin Wood(Chief Financial Officer)in William Bertrand(Chief Operating Officer)in John Lunger(Chief Patient Supply Officer)inElliot Norry(Chief Medical Officer)in

Co-investorsAvoro Capital Advisors Eight Roads Ventures F-Prime Capital Foresite Capital Ridgeback Capital

Addex Therapeuticsaddextherapeutics.com in 𝕏NASDAQ: ADXN

Addex Therapeutics is a clinical-stage pharmaceutical company that develops orally available small molecule drugs known as allosteric modulators for neurological disorders.

BiotechHealthtechGeneva

Roger Mills(Executive Officer, Director)inMikhail Kalinichev(Executive Officer)in Jean-Philippe Rocher(Executive Officer)in Robert Lutjens(Executive Officer)inTimothy Dyer(Executive Officer, Director)Vincent Lawton(Director)

Co-investorsSofinnova Partners ACORN BIOVENTURES SR One Capital Management

Akari Therapeuticsakaritx.com in 𝕏NASDAQ: AKTX

Akari Therapeutics is an oncology biotechnology company developing antibody drug conjugates (ADCs) built on a proprietary PH1 spliceosome-modulating payload that disrupts RNA splicing in cancer cells.

BiotechDeep TechHealthtechTampa, US

Kameel Farag(Interim Chief Financial Officer)in Abizer Gaslightwala(President and Chief Executive Officer)inGur Roshwalb(Executive Officer, Director)inClive Richardson(Executive Officer, Director)inDov Elefant(Executive Officer)Ray Prudo(Director)

Amplitudeamplitude.com in 𝕏NASDAQ: AMPL

Amplitude provides an AI analytics platform that helps companies understand customer behavior and make data-driven product decisions.

Data & InfrastructureDeveloper ToolsEnterprise SoftwareMarketing TechSaaSSan Francisco, US

Spenser Skates(Chief Executive Officer, Co-founder)in Curtis Liu(Chief Technology Officer, Co-founder)in Jeffrey Wang(Co-Founder)in Andrew Casey(Chief Financial Officer)in Nathaniel Crook(Chief Commercial Officer)in

Board Pat Grady(Director)in

Co-investorsBattery Ventures Sequoia Capital 91 Ventures Artisanal Ventures BoxGroup DCVC (Data Collective)+19 more

Black Diamond Therapeutics, Incblackdiamondtherapeutics.comNASDAQ: BDTX

Black Diamond Therapeutics develops small-molecule kinase inhibitors targeting families of oncogenic mutations across cancer types, including its lead candidate silevertinib for EGFR-mutant lung cancer and glioblastoma.

Elizabeth Buck(Chief Scientific Officer)inBrent Hatzis-Schoch(Chief Operating Officer and General Counsel)inSergey Yurasov(Chief Medical Officer)inMelanie Morrison(Chief Development Officer)

Co-investorsLAV Lilly Asia Ventures Nextech Invest NSG Ventures RA Capital Versant Ventures +3 more

Bloom Energybloomenergy.com in 𝕏NYSE: BE

Bloom Energy manufactures solid oxide fuel cell systems for onsite power generation at commercial, industrial, and data center facilities.

CleantechEnergyHardware

K.R. Sridhar(Founder, Chairman, and CEO)KR Sridhar, PhD(Founder, Chairman and Chief Executive Officer)

Co-investorsAlumni Ventures Artis Ventures ATEL Ventures Constellation Technology Ventures Dag Ventures Enerdigm Ventures +10 more

Boston Scientificbostonscientific.com inNYSE: BSXAcquired

Boston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

HealthtechMedical Devices

John AbeleinPeter Nicholas Lance Bates inJonathan R. Monson(Executive Vice President and Chief Financial Officer)Miriam O'Sullivan(Senior Vice President, Chief Human Resources Officer)inMichael F. Mahoney(Chairman of the Board, President and Chief Executive Officer)

Co-investorsAndera Partners Catalyst Health Ventures Council Excelestar Ventures Good Growth Capital Kleiner Perkins +7 more

Boxbox.com in 𝕏NYSE: BOXJul 2012

Box provides intelligent content management and secure collaboration for enterprise teams, combining unstructured data access and sharing with AI-powered workflows and insights.

AI & Machine LearningCloud ComputingEnterprise SoftwareSan Jose, US

Dylan Smith(Executive Officer)in Aaron Levie(Executive Officer, Director)in Dan Levin(Director)in Stephanie Carullo(Executive Officer)in Peter McGoff(Executive Officer)in Graham Younger(Executive Officer)in

Co-investorsAndreessen Horowitz Bessemer Venture Partners Coatue Management Emergence Capital Partners Hercules Capital, Inc.Kleiner Perkins +37 more

Celcuitycelcuity.com in 𝕏NASDAQ: CELC

Celcuity is a commercial-stage biotechnology company developing targeted cancer therapies for tumors involving the PAM (PI3K/AKT/mTOR) pathway, including breast, prostate, lung, endometrial, colon, and ovarian cancers.

BiotechHealthtechMedical DevicesMinneapolis, US

Lance G. Laing(Executive Officer, Director, Promoter)inBrian F. Sullivan(Executive Officer, Director, Promoter)inLance G. Laing, Ph.D.(Chief Science Officer, Vice President, Secretary and Director)Vicky Hahne(Executive Officer)in

Board David F. Dalvey(Director)inRichard E. Buller(Director)

Co-investorsBrightstone Venture Capital

Champions Oncologychampionsoncology.com in 𝕏NASDAQ: CSBR

Champions Oncology offers a KRAS-focused preclinical platform built on patient-derived xenograft (PDX) models screened with the pan-RAS(ON) inhibitor daraxonrasib, combining in vivo pharmacology with multi-omic characterization to study drug response and resistance.

AI & Machine LearningBiotechHealthtechHackensack, US

Ronnie Morris(Executive Officer, Director)inRonnie Morris, M.D.(Executive Officer, Director)inJames McGorry(Executive Officer)David Miller(Chief Financial Officer)inJoel Ackerman(Executive Officer, Director)in Rob Brainin(Chief Executive Officer)in

Co-investorsBattery Ventures Israel Biotech Fund

Cylanceblackberry.com inNYSE: BBAcquired

BlackBerry operates two divisions focused on security and innovation: one providing end-to-end encryption and zero-trust identity control for governments and critical industries, and another offering QNX embedded software and real-time operating systems used in over 275 million vehicles worldwide.

CybersecurityEnterprise SoftwareIoTIrvine, US

Stuart McClure(Executive Officer, Director)inJeffrey Ishmael(Executive Officer)

BoardPatrick Heim(Director)Mark Hatfield(Director)Alex Doll(Director)Alexander Weiss(Director)

Co-investorsClearSky Crosslink Capital Dell Technologies Capital Draper Associates Junipero Khosla Ventures +6 more

Duolingoduolingo.com in 𝕏NASDAQ: DUOLSep 2012 · $45M

Duolingo offers app-based language learning through short, game-like lessons that teach reading, writing, listening, and speaking, using AI and language science to personalize the experience.

AI & Machine LearningConsumerEdTechPittsburgh, US

Severin Hacker(Co-founder and CTO)in Luis von Ahn(Co-founder and CEO)inMatt Skaruppa(Chief Financial Officer)in

Board Brad Burnham(Director)inAndrew Moore(Director)

Co-investorsCapitalG Drive Capital Felicis Ventures Firebolt Ventures Management Company, Llc K2 Global Kleiner Perkins +9 more

Elasticelastic.co in 𝕏NYSE: ESTCJun 2014

Elastic develops search-powered software for enterprises, offering products for search, observability, and security built on Elasticsearch.

AI & Machine LearningCloud ComputingCybersecurityData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US

Teunis Steven Schuurman(Director)Steven Schuurman(Co-founder, former Chief Executive Officer and current director)Uri Boness(Co-founder and former engineering/product leader)in Simon Willnauer(Co-founder and former Elasticsearch engineer)inShay Banon(Founder and CTO)inW.H. Baird Garrett(Executive Officer)

Co-investorsAmplify Partners DCVC (Data Collective)Index Ventures Night Capital Norwest Venture Partners Sierra Ventures +2 more

Enliven Therapeuticsenliventherapeutics.com inNASDAQ: ELVN

Enliven Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops small molecule therapeutics using a precision medicine approach, with a focus on oncology and hematology.

BiotechHealthtechBoulder, US

Sam Kintz(Co-founder and Head of Pipeline)inJoe Lyssikatos(Co-founder and Research Fellow)Anish Patel(Co-founder and Chief Operating Officer)Rick Fair(Chief Executive Officer and Member of the Board of Directors)inHelen Collins(Chief Medical Officer)in Ben Hohl(Chief Financial Officer and Head of Corporate Development)in

Co-investors5AM Ventures OrbiMed Pfizer Venture Investments Roche Venture Fund ARCH Venture Partners Bay City Capital +2 more

Fiscal Notefiscalnote.com in 𝕏OTC: NOTEJan 2013

FiscalNote provides AI-powered software that aggregates and interprets legislative and regulatory data to help organizations track and influence policy outcomes.

AI & Machine LearningData & InfrastructureGovTechSaaSWashington, US

Tim Hwang(Co-founder)inGerald Yao(Co-founder)in Jonathan Chen(Co-founder)inPaul Donnell(Chief Accounting Officer)inJon Slabaugh(CFO and Senior VP of Corporate Development)in Richard Henderson(Executive Officer)in

Co-investors645 Ventures Arrowroot Capital Chaac Ventures Conversion Capital Dorm Room Eastward Capital Partners +22 more

Force10dell.com inNYSE: DELL

Dell designs and sells computing hardware including laptops (XPS, Alienware gaming), monitors, webcams, and PowerEdge servers, along with IT lifecycle management and support services.

ConsumerEnterprise SoftwareHardwareRound Rock, US

Michael Dell(Chairman & CEO)in Michael S. Dell(Chairman of the Board and Chief Executive Officer)in

Co-investorsIcon Ventures Jackson Square Ventures Partners for Growth Partners for Growth (PFG)Utah Governor’s Office of Economic Development (GOED)

Gerongeron.com inNASDAQ: GERN

Geron is a biopharmaceutical company focused on developing therapies for blood cancer.

BiotechHealthtechLongevityMedical Devices

Michael D. WestHarout Semerjian(President and Chief Executive Officer)in Michelle J. Robertson(Executive Vice President, Chief Financial Officer, Treasurer and Interim Secretary)in Joseph Eid(Executive Vice President, Research and Development, Chief Medical Officer)in Ahmed ElNawawi(Executive Vice President, Chief Commercial Officer)in

Co-investorsBioBrit Venrock

Gossamer Biogossamerbio.com in 𝕏NASDAQ: GOSS

Gossamer Bio is a clinical-stage biopharmaceutical company developing seralutinib, an investigational drug candidate for treating pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

BiotechDigital HealthMedical DevicesSan Diego, US

Faheem Hasnain(Executive Officer, Director)inChristian Waage(Executive Officer)in Sheila Gujrathi, MD(Founder)inBryan Giraudo(Executive Officer)Laura Carter, Ph.D.(Executive Officer)Robert Smith(Executive Officer)

Co-investorsARCH Venture Partners Bay City Capital EcoR1 Capital Foothill Ventures Pivotal Life Sciences Samsara BioCapital +3 more

Groupon, Inc.groupon.com in 𝕏NASDAQ: GRPN

Groupon operates a marketplace connecting consumers with discounted deals from local and national merchants across restaurants, beauty services, travel, entertainment, and retail products.

E-commerceMarketplacesRetail Tech

Andrew Mason(Founder)in Dusan Senkypl(Chief Executive Officer)in Jiri Ponrt(Chief Operating Officer)inRana Kashyap(Chief Financial Officer)in

Co-investorsAccel Andreessen Horowitz Battery Ventures Interlace Ventures Maveron Pale Fire Capital +4 more

ImaraNASDAQ: ELVNMar 2019 · $63Macquired by Enliven Therapeutics · Feb 2023

Imara is a clinical-stage biopharmaceutical company developing small molecule therapeutics for unmet medical needs, currently advancing ELVN-001, a selective kinase inhibitor designed to treat chronic myeloid leukemia by targeting the BCR-ABL gene fusion.

BiotechCambridge, US

James G. McArthur(Executive Officer, Director)Christoph M. Adams(Executive Officer, Director)Richard Fair(President, Chief Executive Officer, Director)

BoardSara Nayeem(Director)Barbara Dalton(Director)David Mott(Director)

Co-investorsBay City Capital RA Capital Alexandria Arix Bioscience Lundbeckfonden Ventures OrbiMed +2 more

Iridex Corporationiridex.com in 𝕏NASDAQ: IRIX

Iridex makes laser systems, EndoProbe handpieces, and vitreoretinal surgical consumables used for precision eye surgery in hospitals and ambulatory surgery centers.

HardwareHealthtechMedical DevicesMountain View, US

Patrick Mercer(Chief Executive Officer)inRomeo Dizon(Executive Officer)

BoardYu-Hao Chen(Director)Scott Shuda(Director)William Moore(Director)Beverly Huss(Director)

Co-investorsIncubic Management LLC

Korro Biokorrobio.com in 𝕏NASDAQ: KRROMay 2019 · $70M

Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.

BiotechHealthtechCambridge, US

Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)in Jean-François Formela(Director)in Ommer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)in Ram Aiyar(Chief Executive Officer, President and Director)in Todd Chappell(Chief Operating Officer)in

Board Jean-Francois Formela(Director)in

Co-investorsAtlas Venture MC Healthcare Ventures Alexandria Qiming Venture Partners USA Rock Springs Capital Taiwania Capital +1 more

Lexicon Pharmaceuticalslexpharma.com inNASDAQ: LXRX

Lexicon Pharmaceuticals develops and commercializes pharmaceutical products, including the marketed drug INPEFA and drug candidates in clinical development such as sotagliflozin, pilavapadin, and LX9851, serving patients in need of treatments across various therapeutic areas.

BiotechThe Woodlands, US

Brian P. Zambrowicz(Executive Officer)inBrian T. Crum(Executive Officer)inRachel Martens(Executive Officer)inScott Coiante(Executive Officer)Craig B. Granowitz(Executive Officer)inWendy E. McDermott(Executive Officer)in

Liquidia Corporationliquidia.com inNASDAQ: LQDAApr 2021

Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

BiotechMorrisville, US

Damian deGoa(Executive Officer, Director)inMichael Kaseta(Executive Officer)in

Board Paul B. Manning(Director)in Stephen Bloch(Director)inJoanna Horobin(Director)Raman Singh(Director)

Co-investorsCanaan Partners Xeraya Capital PBM Capital

Marker Therapeuticsmarkertherapeutics.com inNASDAQ: MRKR

Marker Therapeutics develops novel T cell therapies, including adoptive T cell therapy approaches, for clinical applications in oncology and other diseases with high unmet need.

BiotechHealthtechHouston, US

Juan Vera(Executive Officer, Director)inDr. Vera(Co-founder)Glynn Wilson(Executive Officer, Director)John Bonfiglio(Executive Officer, Director)

Board Steven Elms(Director)inJohn Wilson(Director)

Co-investorsAisling Capital

Mirna Therapeuticsblogmedicina.com 𝕏OTC: SYBX

A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.

BiotechMedia & EntertainmentAustin, US

Matthew Winkler(Director)Sinil Kim(Executive Officer)in Paul Lammers(Executive Officer, Director)inJon Irvin(Executive Officer)Casi DeYoung(Executive Officer)

BoardMichael Powell(Director)

Co-investorsPfizer Venture Investments Correlation Ventures OrbiMed Osage University Partners OUP (Osage University Partners)Pfizer Ventures +1 more

MongoDBmongodb.com in 𝕏NASDAQ: MDBDec 2014

MongoDB is a cloud database company that provides Atlas, a multi-cloud data platform for transactional, search, and generative AI workloads, along with enterprise on-premises options and integration tools for developers and partners.

AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsNew York, US

Dwight Merriman(Co-founder)in Eliot Horowitz(Co-founder; CTO until 2020)inChirantan 'CJ' Desai(President and Chief Executive Officer)Sydney Carey(Chief Financial Officer)in Dev Ittycheria(Chief Executive Officer)in

Board Roelof Botha(Director)in

Co-investorsAlleyCorp Dell Technologies Capital Flybridge Capital Partners Foundry MaC Venture Capital Open Field Capital +4 more

Nektar Therapeuticsnektar.com inNASDAQ: NKTR

Nektar develops therapies that modulate the immune system to treat autoimmune diseases and inflammatory conditions, targeting the root causes of immune dysfunction.

BiotechHealthtechSan Francisco, US

Howard W. Robin(Executive Officer, Director)Gil M. Labrucherie(Executive Officer)inManinder Hora(Executive Officer)inStephen K. Doberstein(Executive Officer)John Nicholson(Executive Officer)Jillian B. Thomsen(Executive Officer)

Co-investorsHEALTHCARE ROYALTY PARTNERS

NeuroPaceneuropace.com in 𝕏NASDAQ: NPCEAug 2020

NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.

Digital HealthHardwareHealthtechMedical DevicesMountain View, US

Rebecca Kuhn(Executive Officer)inFrank Fischer(Executive Officer, Director)Joel Becker(President, Chief Executive Officer and Director)inVince Burgess(Director)in Renee Ryan(Director)inRay Larkin(Director)

Co-investorsAccelmed Partners OrbiMed

Nextnavnextnav.com in 𝕏NASDAQ: NN

NextNav builds positioning, navigation, and timing (PNT) services using spectrum as a complement and backup to GPS, addressing vulnerabilities in indoor, urban, and critical infrastructure environments.

Deep TechDefense TechIoTSpace TechReston, US

Arun Raghupathy(Co-Founder and Chief Technology Officer)inGanesh Pattabiraman(Chief Executive Officer)MARIAM SOROND(Executive Officer, Director)in SUSAN INSLEY(Executive Officer)in JAMES BLACK(Executive Officer)inCHRISTIAN GATES(Executive Officer)in

Co-investorsColumbia Capital Oak Investment Partners

Omada Healthomadahealth.com in 𝕏NASDAQ: OMDA

Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)in Sean Duffy(Executive Officer, Director)in Wei-Li Shao(President)in Steve Cook(Chief Financial Officer)in

BoardJonathan Root(Director)in

Co-investorsaMoon Andreessen Horowitz Blackbird Giants Canvas Ventures Civilization Ventures Management, Llc Designer Fund +14 more

Opendooropendoor.com in 𝕏NASDAQ: OPENJun 2018

Opendoor offers instant cash offers for residential properties through real estate agents, allowing sellers to choose between a fast sale or list the home later.

B2B MarketplacesE-commerceMarketplacesPropTechPhoenix, US

Eric Wu(Co-founder)inJD Ross(Cofounder)Keith Rabois(Co-founder)in Kaz Nejatian(Chief Executive Officer)in

Co-investorsA*Access Technology Ventures AirTree Ventures Andreessen Horowitz Blue Lion Global Coatue Management +39 more

ORIC Pharmaceuticalsoricpharma.com inNASDAQ: ORIC

ORIC Pharmaceuticals is a clinical-stage oncology company developing therapies aimed at overcoming cancer treatment resistance, including innate, acquired, and bypass resistance.

BiotechHealthtechSouth San Francisco, US

Richard Heyman(Chairman, Founder, Scientific Advisory Board)in Charles Sawyers(Founder, Scientific Advisory Board)Scott Lowe(Founder, Scientific Advisory Board)Dominic Piscitelli(Chief Financial Officer)in Pratik Multani(Chief Medical Officer)inJacob Chacko(President, Chief Executive Officer and Board Member)in

Co-investorsEcoR1 Capital Nextech Invest Taiho Ventures, LLC The Column Group OrbiMed

PagerDutypagerduty.com in 𝕏NYSE: PD

PagerDuty provides a platform for incident response and operations management that enables teams across technical and business functions to respond to critical events in real time.

AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Alex Solomon(Founder/CTO)inDan Alexandru Solomon(Director)Jennifer Tejada(Executive Chair)in Steven Gatoff(Executive Officer)in John DiLullo(Chief Executive Officer)in

Board John O'Farrell(Director)in

Co-investorsAccel Andreessen Horowitz Aurum Baseline Ventures Bessemer Venture Partners Bling Capital +17 more

PayPalpaypal.com inNASDAQ: PYPLFeb 2025 · $63M

PayPal is the payments company that came out of the March 2000 merger of Confinity — founded in 1998 by Max Levchin, Peter Thiel, Luke Nosek and Ken Howery to beam money between Palm Pilots — and Elon Musk's online bank X.com.

San Jose, US

Max Levchin(Co-founder & CTO)in Peter Thiel(Co-founder & CEO)in Luke Nosek(Co-founder & VP Marketing Strategy)in Ken Howery(Co-founder & CFO)in Elon Musk(Co-founder (X.com); CEO 2000)in Alex Chriss(President and Chief Executive Officer)in

Co-investorsA*BlueRun Ventures Clearstone Venture Partners DG Daiwa Ventures Mercury Fund Sequoia Capital +5 more

Sagimet Biosciencessagimet.com inNASDAQ: SGMTFeb 2019 · $18M

Sagimet is a clinical-stage biopharmaceutical company developing therapies targeting fatty acid synthase (FASN) for metabolic diseases and oncology.

BiotechDigital HealthHealthtechMenlo Park, US

Rekha Hemrajani(Executive Officer)inMerdad Parsey(Executive Officer, Director)inDavid Happel(Chief Executive Officer & Director)Andreas Grauer(Chief Medical Officer)inThierry Chauche(Chief Financial Officer)inMarie O'Farrell(Chief Scientific Officer)in

Co-investorsAltium Capital HM Venture Partners Kleiner Perkins BAM Elevate Biotechnology Value Fund Blue Owl Capital +1 more

Savarasavarapharma.com inNASDAQ: SVRA

Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.

BiotechHealthtechMedical DevicesAustin, US

Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)inMike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)inSantosh J. Vetticaden(Executive Officer)Gregory D. Gorgas(Executive Officer)Patrick Keran(Executive Officer)

Co-investorsBain Capital Life Sciences Central Texas Angel Network Green Park & Golf Ventures Keiretsu Forum Moore Venture Partners

SenseonicsNASDAQ: SENS

Senseonics develops and commercializes an implantable continuous glucose monitoring system called Eversense that measures blood glucose levels for extended periods (up to 12 months) via a subcutaneous sensor and rechargeable transmitter, serving people with diabetes as an alternative to conventional CGM devices that require replacement every 1-2 weeks.

BiotechGermantown, US

Mirasol Panlilio(Executive Officer)inR. Don Elsey(Executive Officer)Mukul Jain(Executive Officer)Timothy T. Goodnow(Executive Officer, Director)Francine R. Kaufman(Chief Medical Officer)inBrian Hansen(Chief Commercial Officer)

Senseonics Holdingssenseonics.comNASDAQ: SENS

Senseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to measure blood sugar levels for up to one year in people with diabetes, offering an alternative to conventional glucose monitors that require more frequent sensor replacement.

BiotechGermantown, US

Mukul Jain(Executive Officer)Francine R. Kaufman(Executive Officer, Director)in Rick Sullivan(Executive Officer)inKenneth L Horton(Executive Officer)Timothy T. Goodnow(Executive Officer, Director)Mirasol Panlilio(Executive Officer)in

Co-investorsVensana Capital

Snapsnapchat.com inNYSE: SNAPApr 2014

Snapchat is a mobile app for communicating with friends and family through photos and videos, featuring augmented-reality Lenses, creative sharing tools, and a personalized map for discovering places and content.

ConsumerCreator EconomyMedia & EntertainmentSocialSanta Monica, US

Evan Spiegel(Co-founder and CEO)in Bobby Murphy(Co-founder and CTO)Reggie Brown(Co-founder)Tim Sehn(Executive Officer)Emily White(Executive Officer)in Derek Andersen(Chief Financial Officer)in

Co-investorsA-Rod Corp Access Technology Ventures Alibaba Group CapitalG Coatue Management Entrée Capital +33 more

Surf Airsurfair.com in 𝕏NYSE: SRFM

Surf Air Mobility operates regional air travel across the U.S. through scheduled flights, on-demand private charter booking, and electric aviation technology.

CleantechMobility & TransportationTravel & HospitalityHawthorne, US

Sudhin Shahani(Director)inOliver Reeves(Executive Officer)Tyler Painter(Director)Deanna White(Executive Officer)inJames Bailey(Director)Bruce Gonzalez(Executive Officer)

Co-investorsAnthem Venture Management, Llc Baroda Ventures Base Venture Management, Inc.Ff Venture Capital Mucker Capital Partners for Growth +7 more

Trevi Therapeuticstrevitherapeutics.com in 𝕏NASDAQ: TRVI

Trevi Therapeutics is a clinical-stage biopharmaceutical company developing Haduvio (oral nalbuphine ER), an investigational therapy for chronic cough that targets the central and peripheral cough reflex arc.

BiotechHealthtechNew Haven, US

Thomas Sciascia(Executive Officer)Jennifer Good(Co-Founder, President and CEO)inThomas Sciascia, M.D.(Co-Founder, Chief Scientific Officer)Lisa Delfini(Executive Officer)in William Forbes(Executive Officer)inMichael Heffernan(Director)in

Co-investorsAPERTURE Venture Partners Frazier Life Sciences Pivotal Life Sciences Omega Funds

Tuyatuya.com in 𝕏NYSE: TUYA

Tuya's LLM solution provides integrated AI services and customizable AI Copilot development tools that let businesses build, deploy, and evaluate large language models across sectors including real estate, healthcare, retail, and manufacturing.

AI & Machine LearningCloud ComputingEnterprise SoftwareHardwareIoT

Co-investorsATM Capital Qiming Venture Partners Vision Plus Capital

Uberuber.com in 𝕏NYSE: UBER

Uber operates a multi-sided platform providing ride-sharing, food delivery, freight logistics, and business fleet management services across various global markets.

Logistics & Supply ChainMarketplacesMobility & TransportationSan Francisco, US

Travis Kalanick(Co-founder; CEO until 2017)Garrett Camp(Co-founder)in Gautam Gupta(Executive Officer)inJeffrey Holden(Executive Officer)David Plouffe(Executive Officer)in Emil Michael(Executive Officer)in

Co-investors137 Ventures 3Spoke Capital 408 Ventures A*ACME Capital Across Capital Partners +79 more

Upstartupstart.comNASDAQ: UPST

Upstart is an AI lending marketplace that partners with banks and credit unions to underwrite personal, auto and small-dollar loans on more than traditional credit scores; it went public on the Nasdaq in December 2020.

Palo Alto, US

Paul Gu(Cofounder)Dave Girouard(Chief Executive Officer; Chairperson of the Board)in Alison Nicoll(Executive Officer)inRyan Randall(Executive Officer)Sanjay Datta(CFO of Administrator, Upstart Network, Inc.)in

Board Rob Schwartz(Director)in

Co-investorsAlumni Ventures Ballistic Ventures Basecamp Fund Collaborative Fund Correlation Ventures Eudemian Ventures +12 more

Upworkupwork.comNASDAQ: UPWK

Upwork operates two interconnected digital platforms that match businesses with independent contractors and agency workers: the Upwork Marketplace, a freelance work platform where clients post projects and pay service fees on transactions, and Lifted, an enterprise-focused platform for managing contingent labor across multiple engagement models including contractors, staff augmentation, and outsourcing.

Hayden Brown(Chief Executive Officer)inGiulietta Pezzaniti(Chief People Officer)

Co-investors3Spoke Capital 408 Ventures Dag Ventures FirstMark Capital Garage Capital Globespan Capital Partners +8 more

VistaGen Therapeuticsvistagen.comNASDAQ: VTGN

VistaGen Therapeutics develops intranasal pherine compounds targeting neuropsychiatric and women's health conditions through a mechanism that activates nasal sensory neurons to modulate brain circuits without systemic absorption.

BiotechSouth San Francisco, US

H. Ralph Snodgrass(Executive Officer, Director)Jerrold D. Dotson(Executive Officer)Shawn K. Singh(Executive Officer, Director)inA. Franklin Rice(Vice President of Corporate Development)

BoardUnderdown J. Brian(Director)Gregory A. Bonfiglio(Director)

Workdayworkday.com in 𝕏NASDAQ: WDAYApr 2009

Workday provides a cloud-based platform that uses AI agents to automate and manage HR, finance, IT, legal, and frontline operations processes for enterprises and midsize businesses.

AI & Machine LearningEnterprise SoftwareHR TechSaaSPleasanton, US

Aneel Bhusri(Co-founder and Executive Chair; CEO until 2024)inDavid A. Duffield(Co-founder; CEO until 2009)Michael Stankey(Executive Officer)James Shaughnessy(Executive Officer)C. Christopher Watts(Executive Officer)Rob Enslin(President, Chief Commercial Officer)in

Co-investorsGreylock Partners T. Rowe Price Bezos Expeditions

X4 Pharmax4pharma.com in 𝕏NASDAQ: XFOR

X4 Pharmaceuticals is a biopharmaceutical company developing medicines for people living with rare immune disorders, including chronic neutropenia.

BiotechBoston, US

Mary DiBiase(Executive Officer)inChristophe Arbet-Engels(Executive Officer)inDavid Kirske(Executive Officer)inJohn Volpone(Executive Officer)inMark Baldry(Executive Officer)Adam Craig(Executive Officer, Director)in

Co-investorsBain Capital Life Sciences Lumira Ventures Partners Resolute Thynk Capital Advent Life Sciences Omega Funds +1 more

Xenon Pharmaceuticalsxenon-pharma.com in 𝕏NASDAQ: XENESep 2018 · $63M

Xenon is a neuroscience-focused biopharmaceutical company that discovers and develops ion channel modulators as therapeutics for neurological and psychiatric disorders.

BiotechHealthtech

Ian Mortimer(President and Chief Executive Officer)in Darren Cline(Chief Commercial Officer)in Andrea DiFabio(Chief Legal Officer and Corporate Secretary)in James Empfield(Executive Vice President, Drug Discovery)inTucker Kelly(Chief Financial Officer)in Chris Kenney(Chief Medical Officer)in

Co-investorsArcher Capital Group Archer Venture Capital Avoro Capital Advisors Foresite Capital

Zenas Biopharmazenasbio.com inNASDAQ: ZBIO

Zenas BioPharma is a biopharmaceutical company developing therapies for autoimmune diseases, with two late-stage drug candidates: obexelimab, a bifunctional monoclonal antibody targeting CD19 and FcγRIIb to suppress B cell activity, and orelabrutinib, an oral BTK inhibitor.

BiotechHealthtechWaltham, US

LEON O. MOULDER, JR.(Director)Lonnie Moulder(Founder, CEO & Chairman)JOSEPH FARMER(Executive Officer)HUA MU(Executive Officer, Director)in

Board PATRICK GERALD ENRIGHT(Director)inHONGBO LU(Director)

Co-investorsDelos Capital Longitude Capital Norwest Venture Partners Pivotal Life Sciences Quan Capital SR One Capital Management +2 more

floxfloxdev.com in 𝕏Aug 2025 · $25M✓ verified

Flox provides tooling to manage software and its dependencies down to individual packages, including SBOMs and provenance, with reproducible environments that work across the software lifecycle.

AI & Machine LearningCloud ComputingCybersecurityDeveloper ToolsEnterprise SoftwareNew York City, US

Ron Efroni Rotman(Executive Officer, Director)Michael Brantley(CTO)in Ron Efroni(CEO)inBen Futoriansky(Executive Officer)in

Board Pavel Livshiz(Director)in

Board seat Aaron Jacobson· per SEC Form D

Co-investorsHetz Ventures Angel Collective Opportunity Fund Essence Venture Capital Firestreak Ventures Maximilian Stoiber Tilia Impact Ventures +6 more

IonQ (IONQ)ionq.com in 𝕏Jul 2016✓ verified

IonQ builds trapped-ion quantum computing systems along with quantum networking, sensing, and security products, offering commercial systems accessible through major cloud providers and integration with common quantum libraries.

Deep TechHardwareQuantum ComputingCollege Park, US

Jungsang Kim(Co-founder)in Chris Monroe(Co-founder)in

Board David Moehring(Executive Officer, Director)inBlake Byers(Director)

Board seatRon Bernal Andrew Schoen· per SEC Form D

Co-investorsACME Capital BlueYard Capital Breakthrough Energy Ventures Cambium Capital Cota Capital Grit Ventures +6 more

SetPoint Medicalsetpointmedical.com in 𝕏Mar 2025✓ verified

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.

BiotechHealthtechMedical DevicesValencia, US

Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)in

Board Juan-Pablo Mas(Director)in

Board seat Blake Wu· per SEC Form D

Co-investorsAlly Bridge Group Norwest Venture Partners Topspin Partners Asahi Kasei Corporate Venture Capital Catalio Capital Management, LP Citta Capital +6 more

Abcuroabcuro.com✓ verified

Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.

BiotechHealthtechNewton, US

Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)

Co-investorsBain Capital Life Sciences RA Capital Samsara BioCapital Sanofi Ventures Mass General Brigham Ventures REDMILE +9 more

Aeraaeratechnology.com in 𝕏✓ verified

Aera Technology builds Aera, a decision intelligence platform that unifies data, analytics, AI, and automation to automate and optimize operational decisions across large enterprises.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaSMountain View, US

Co-investorsNewView Capital Harmony Partners

Almatryalma.com in 𝕏✓ verified

Alma is a modern immigration law firm serving both companies and individuals, where attorneys handle US visa and green card cases such as O-1, H-1B, and EB-2/EB-1 petitions.

AI & Machine LearningHR TechLegalTechSaaSPalo Alto, US

Shuo Chen(Founder)in Aizada Marat(Co-founder)in Assel Tuleubayeva(Co-founder)in

Co-investorsBling Capital MVP Ventures Conviction NFX Village Global Mento vc +8 more

Assembledassembled.com in 𝕏Series B · May 2022 · $51M✓ verified

Assembled provides workforce management software with a forecasting tool that predicts support volume and staffing needs across channels, queues, and sites for in-house, outsourced, and AI-automated customer support teams.

AI & Machine LearningEnterprise SoftwareFuture of WorkSaaSSan Francisco, US

John Wang(Founder)inBrian Sze(Founder)inRyan Wang(Founder)in

Co-investorsBasis Set Ventures Earl Grey Capital Emergence Capital Partners SignalFire Stripe

Bliqbliq.app in 𝕏✓ verified

Bliq develops autonomous driving technology to make private cars driverless.

Deep TechMobility & TransportationRoboticsBerlin, DE

Johannes Riedel(Founder)in

Co-investorsProeza Ventures TechFounders Speedinvest

Bralebrale.xyz in 𝕏Feb 2023 · $11.1M✓ verified

Brale provides infrastructure to simplify the creation and deployment of regulated stablecoins, reducing the time, cost, and complexity for builders, businesses, and networks to issue digital dollars.

Crypto & Web3FintechSaaS

Co-investorsLightspeed Venture Partners Foundation Capital Refract Ventures The Fintech Fund

Brenigbrenigther.com in 𝕏✓ verified

Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery.

AI & Machine LearningBiotechHealthtechDover, US

Megan McGill(Chief Executive Officer)in Iain Dukes(Chief Business Officer / Chairman of the Board)in Nikolay Savchuk(Chief Operating Officer)Tien Dam(Chief Medical Officer)in

Co-investorsOrbiMed BGV Torrey Pines Investment

Cleohicleo.com in 𝕏Mar 2019✓ verified

Cleo is a family care platform offered as an employer benefit, providing personalized caregiving support across life stages including parenting, mental health, cancer, chronic conditions, and elder care.

Digital HealthHR TechWellness & FitnessSan Francisco, US

Chitra Akileswaran(Co-Founder & Chief Medical Officer)in Madhavi Vemireddy(CEO (as of 2025-2026); previously Chief Clinical Officer)inSarahjane Sacchetti(Former CEO)inTyler Hoersch(Chief Technology Officer)

BoardKarin Ajmani(Director / Board Member)

Co-investorsGreylock Partners TRANSFORMATION CAPITAL Felicis Ventures Forerunner Ventures Glynn Capital Management Ingeborg Investments +5 more

Clockworkclockwork.io in 𝕏Mar 2022 · $21M✓ verified

Clockwork provides infrastructure software for running large-scale AI training and inference workloads on GPU clusters, using nanosecond-precision monitoring, auto-remediation, and stateful job failover to prevent job crashes and reduce restarts.

AI & Machine LearningCloud ComputingData & InfrastructurePalo Alto, US

Deepak Merugu(Founder)in

Co-investorsJC2 Ventures Sherpalo Ventures

Cohere Technologiescohere-technologies.com in 𝕏Feb 2022 · $46M✓ verified

Cohere Technologies develops software for mobile and wireless networks, including its Universal Spectrum Multiplier (USM) for 4G and 5G and Pulsone technology based on the Zak-OTFS waveform, aimed at Mobile Network Operators.

AI & Machine LearningCloud ComputingDeep TechDefense TechEnterprise SoftwareHardwareSanta Clara, US

Shlomo Rakib(Executive Officer, Director)in

BoardRon Bernal(Director)inKrishna Kolluri(Director)Chris Schaepe(Director)

Co-investorsLightspeed Venture Partners Bell Ventures Intel Capital Juniper Koch Disruptive Technologies Longitude Capital +3 more

CoreStory Code intelligencecorestory.ai in 𝕏✓ verified

CoreStory builds a persistent intelligence model of software codebases by continuously ingesting source code and serving system context—architecture, workflows, and business rules—to engineers, product teams, and AI coding agents.

AI & Machine LearningDeveloper ToolsEnterprise Software

Anand Kulkarni(Founder)in

Co-investorsHomebrew SINEWAVE VENTURES Tribeca Venture Partners Bee Partners Jackson Square Ventures Tech Square Ventures

CuspAIcusp.ai in 𝕏Series B · Jun 2026 · $450M✓ verified

CuspAI develops AI models for materials science and discovery, and leads the AI Materials Foundry initiative that combines accelerated computing infrastructure with chemistry data and materials expertise.

AI & Machine LearningDeep TechNew MaterialsCambridge, GB

Max Welling(Co-Founder)in Chad Edwards(Co-Founder & CEO)in

Co-investorsBasis Set Ventures Hoxton Ventures Kleiner Perkins Lightspeed Venture Partners Northzone Temasek +19 more

DataVisordatavisor.com in 𝕏✓ verified

DataVisor provides an AI-based platform for financial crime prevention, using machine learning, adaptive AI agents, and automation to detect and block fraud and money laundering in real time.

AI & Machine LearningCybersecurityFintechMountain View, US

Fang Yu(CPO & Co-Founder)in Yinglian Xie(President of Technology and AI & Co-Founder)in Patrick Harr(CEO)in

Board Kevin Fong(Director)in Jon Sakoda(Director)inKai Wang(Director)

Co-investorsBrighton Park Capital Genesis Venture Capital Sequoia Capital NewView Capital TruStage Ventures Decibel Partners +1 more

ExploraMed Vexploramed.comJul 2017✓ verified

ExploraMed is a medical device incubator that develops new med tech companies and products from early-stage concept through development.

BiotechHardwareHealthtechMedical DevicesMountain View, US

Joshua Makower(M.D., Founder and Executive Chairman)Earl A. Bright, II(Executive Officer, Director)Earl "Eb" Bright(President & General Counsel)

BoardIvy Ross(Director)Nina Richardson(Director)Robert Anderson(Director)

GetChangegetchange.io in 𝕏May 2022✓ verified

Change offers a tool for law firms to manage commercial co-venture (CCV) campaigns for their clients, including tracking multi-state filing requirements and deadlines, launching campaigns through a single CCV agreement with a partner donor-advised fund, and processing CCV-related donations.

AI & Machine LearningFintechImpact & Social GoodLegalTechSaaSSan Francisco, US

Amar Shah(Executive Officer, Director)inSonia Nigam(Executive Officer, Director)in

Co-investorsSpice Capital

GoQiigoqii.com in 𝕏✓ verified

GOQii offers a smart health ecosystem that combines wearable technology and app-based tools with expert human coaching for preventive and value-based care.

Digital HealthHealthtechWellness & FitnessMenlo Park, US

A. Vishal Gondal(Executive Officer, Director)inAbhishek Sharma(Founder)in Vishal Gondal(Founder)in

BoardPravin Gandhi(Director)Bala Deshpande(Director)

Co-investorsAnimoca Brands Mitsui & Co DSG Consumer Partners SmartStart Fund Trifecta Capital Advisors

Granicagranica.ai inJun 2023✓ verified

Granica is an AI research and products company that builds enterprise AI infrastructure customers own and run inside their own environment, including Myelin (stateful infrastructure for long-running agents), Crunch (a data lake optimization engine that reduces storage and compute costs), and Large Tabular Models for generative AI on tabular data.

AI & Machine LearningData & InfrastructureEnterprise SoftwareMountain View, US

Rahul Ponnala(Co-founder & CEO)inEdgar Wu(Founder)Sumit Rawat(Founder)inZhen Wang(Founder)

Co-investorsBain Capital 515 Ventures Abstract Ventures SINEWAVE VENTURES Bain Capital Ventures

Gridgrid.is in 𝕏Series A · Aug 2020 · $12M✓ verified

GRID builds spreadsheet technology that lets software teams embed spreadsheet capabilities into their products, with Excel and Google Sheets compatibility, high performance, and AI integration through its own Spreadsheet LLM.

AI & Machine LearningData & InfrastructureDeveloper ToolsSaaSReykjavík, IS

Hjalmar Gislason(Founder & CEO)in Thorsteinn Yngvi Gudmundsson(Co-Founder & VP of Operations & Finance)inBorgar Þorsteinsson(Co-Founder, Engineering)Steinn Eldjárn Sigurðarson(Co-Founder, Engineering)Eva Dogg Steingrimsdottir(VP of Software Development)

Co-investorsAcequia Capital (AceCap)BlueYard Capital Slack Fund Brunnur Ventures GP

Gst Clinicsgstzy.cn✓ verified

Gushengtang operates a chain of traditional Chinese medicine (TCM) clinics, running 101 offline TCM facilities across 21 Chinese cities and Singapore with an online-plus-offline (OMO) service model supported by internet and AI technology.

AI & Machine LearningDigital HealthHealthtechWellness & FitnessGuangzhou, CN

Co-investorsAGP F-Prime Capital

Metronomemetronome.com in 𝕏Series B · Jan 2024 · $43M✓ verifiedAcquired

Metronome provides a usage-based billing platform for SaaS companies, enabling them to launch products faster and make data-driven revenue decisions.

Data & InfrastructureEnterprise SoftwareFintechSaaS

Scott Woody(Founder)inAndrew Garvin(Founder)in

Co-investorsAndreessen Horowitz General Catalyst Elad Gil Activant Capital Mango Capital Nat Turner +4 more

Mythic AImythic.ai in 𝕏✓ verified

Mythic builds analog processing units based on compute-in-memory architecture designed to run AI workloads efficiently in real-world applications.

AI & Machine LearningHardwareSemiconductorsPalo Alto, US

Taner Ozcelik(CEO / Board Member)inSteven Pho(CFO)

Co-investorsCatapult Ventures Linse Capital S3 Ventures Atreides Management DCVC (Data Collective)Lockheed Martin Ventures +13 more

Nexonexotx.com in✓ verified

Nexotx is a drug discovery company that identifies and develops medicines targeting previously undrugged biological pathways using chemical biology approaches.

AI & Machine LearningBiotechDeep Tech

Andrew Phillips(President and Chief Executive Officer)

Co-investorsVersant Ventures

P-1 AIp-1.aiSeries A · Jul 2026 · $50M✓ verified

P-1 AI builds Archie, an AI agent designed to function as a junior mechanical and electrical engineer that integrates into engineering teams and uses the same design tools as human engineers.

Advanced ManufacturingAI & Machine LearningDeep TechSan Francisco Bay Area, US

Paul Eremenko in

Co-investorsLerer Hippeau Radical Ventures Schematic Ventures Village Global Predictive VC Vast Ventures +1 more

Plasmicplasmic.app in 𝕏✓ verified

Plasmic is a visual development platform for building web applications and pages, with integrations for tools like Cursor.

Cloud ComputingDeveloper ToolsMarketing TechSaaS

Yang Zhang(Founder)in

Co-investorsDesigner Fund Arrive Tiny Capital Olima Ventures

PlayerZeroplayerzero.ai in 𝕏✓ verified

PlayerZero builds AI agents for support engineering that coordinate work across teams by delegating questions to the right owners and consolidating answers into a single thread.

AI & Machine LearningDeveloper ToolsSaaS

Animesh Koratana(Founder)in

Co-investorsFoundation Capital Green Bay Ventures SV Angel WndrCo BLH Venture Partners, LLC Tech Square Ventures +5 more

Red Ridge Bioredridgebio.comSeed · Jan 2023✓ verified

RedRidge Bio discovers and develops biparatopic antibodies (antibodies that bind two sites on a single protein), including biparatopic antibody-drug conjugates, as therapeutics for oncology and autoimmune diseases.

BiotechHealthtech

Bill Sellers(Scientific Founder and Director Cancer Program, Broad Institute)Stephen Yoder(President & CEO)in

Co-investorsVersant Ventures Sixty Degree Capital

Shape Therapeuticsshapetx.com in 𝕏Nov 2019 · $35.5M✓ verified

ShapeTX develops programmable RNA medicines by combining artificial intelligence with RNA technology to address genetic causes of disease.

AI & Machine LearningBiotechDeep Tech

Josef von Rickenbach, PhD(Co-Founder)in

Co-investorsDecheng Capital Mission Biocapital Highbury Holdings

Slashslash.com in 𝕏Apr 2026 · $100M✓ verified

Slash provides enterprise-grade cash management and deposit insurance services for businesses, offering FDIC coverage expanded across a network of partner banks with real-time transaction controls and approval workflows.

AI & Machine LearningEnterprise SoftwareFintechSaaSSan Francisco, US

Victor Cardenas(CEO)in Kevin Bai(Founder)in Victor Cardenas Codriansky(Founder)in

Co-investorsY Combinator Goodwater Capital Azure Ventures Group Epakon Capital Garage Capital Khosla Ventures +10 more

Smartcarsmartcar.com in 𝕏Series A · Mar 2018 · $10M✓ verified

Smartcar provides an API and integration platform that enables access to connected vehicle data, powering mobility applications and services for consumers and businesses including insurance savings, car-sharing, and electric vehicle adoption.

IoTMobility & TransportationSaaS

Sanketh Katta(Co-Founder)in Sahas Katta(Founder)in

Co-investorsAndreessen Horowitz Energize Capital

Solmeetsol.com in 𝕏✓ verified

Sol is building an AI-native, agentic HR system for growing enterprises, designed to capture how work actually gets done and support decisions by both leaders and AI agents.

AI & Machine LearningEnterprise SoftwareHR Tech

Pete Schlamppin Erin Yang inJim Strattonin Jon Ruggiero in

Co-investorsSutter Hill Ventures DeVC General Catalyst Nexus Venture Partners peercheque

Sorriso Pharmaceuticalssorrisopharma.com inDec 2021✓ verified

Sorriso Pharma is a biopharmaceutical company backed by leading venture capital firms specializing in life sciences and healthcare investments.

BiotechHealthtechMedical DevicesSandy, US

Ciara Kennedy, Ph.D.(Executive Officer, Director)Brian Dorsey(Executive Officer)Michael Grey(Director)Mark Chin(Director)Susan Dube(Executive Officer)

BoardEdward Mathers(Director)

Co-investorsPappas Capital NEA Secondary

Spirashealthspirashealth.com✓ verified

Spiras Health delivers specialized home-based clinical care through nurse practitioners, nurses, and therapists who assess, diagnose, and treat patients with complex chronic illnesses.

Digital HealthHealthtechBrentwood, US

Scott A. Bowers(Chief Executive Officer)

Co-investorsFCA Venture Partners Alumni Ventures Primetime Partners

Splashtopsplashtop.com in 𝕏Jan 2021✓ verified

Splashtop is a remote access and support platform that enables users to securely access and control computers from any device with high performance, up to 4K quality at 60fps.

Cloud ComputingCybersecurityDeveloper ToolsEnterprise SoftwareFuture of WorkSaaS

Mark Lee(Founder)in Robert Ha(Founder)inThomas DenginPhilip Sheuin

Co-investorsSapphire Ventures Storm Ventures DFJ DragonFund Draper Associates Draper Dragon Pointguard Ventures +2 more

Synthesiasynthesia.io in 𝕏Jan 2025 · $180M✓ verified

Synthesia is an AI video platform that lets businesses generate videos with AI avatars and agents, aimed at helping organizations train, onboard, and upskill employees.

AI & Machine LearningEnterprise SoftwareMarketing TechSaaSLondon, GB

Victor Riparbelli(Co-founder & CEO)in Steffen Tjerrild(Co-Founder & COO/CFO)in Lourdes Agapito(Co-Founder)in Matthias Niessner(Co-Founder)in

Co-investorsAccel Air Street Capital FirstMark Capital GV (Google Ventures)Kleiner Perkins MMC Ventures +14 more

Tri Alpha Energytae.com in 𝕏✓ verified

TAE Technologies develops hydrogen-boron (aneutronic) fusion power using a beam-driven Field-Reversed Configuration reactor design, aiming to deliver utility-scale fusion electricity to the grid in the early 2030s.

CleantechDeep TechEnergyFoothill Ranch, US

Norman Rostoker(Co-founder)Michl Binderbauer(CEO)in Cedric Burgher(Chief Financial Officer)in

Co-investorsChevron Technology Ventures Wellcome Trust Capital Factory UpVentures Capital Venrock RUSNANO

Unionunion.ai in 𝕏✓ verified

Union.ai provides a workflow orchestration platform, built on Flyte, that lets biotech and life-sciences teams write and run computational pipelines in pure Python with per-task container images, mixed CPU/GPU compute, and input-hash caching.

AI & Machine LearningBiotechData & InfrastructureDeveloper ToolsSeattle, US

Haytham Abuelfutuh(Founder)inKetan U(Founder)

Co-investorsNava Ventures Frontier Ventures

Valarianvalarian.com inJul 2026✓ verified

Valarian builds ACRA, an infrastructure platform for organizations requiring high levels of control, privacy, and compliance in their digital environments.

Cloud ComputingCybersecurityEnterprise SoftwareLondon, GB

Max Buchan(Co-founder & CEO)inJosh McLaughlin(Co-founder & COO)

Co-investorsArtis Ventures IQ Capital Molten Ventures Scout Ventures Lightbank Founders Factory +5 more

Vesper Medicalvespermedical.com in 𝕏May 2019✓ verified

Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.

HealthtechMedical DevicesWayne, US

Bruce J. Shook(President and CEO)Monica Klos(Executive Officer)inNeil Hattangadi(Director)inPeter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)

Co-investorsGilde Healthcare Lightstone Ventures Vensana Capital 415 Capital

Weaviateweaviate.io in 𝕏Series B · Apr 2023 · $50M✓ verified

Weaviate is a fully remote company with globally distributed teams that works on open-source technology.

AI & Machine LearningData & InfrastructureDeveloper Tools

Co-investorsBattery Ventures Cortical Ventures Index Ventures Zetta Venture Partners ING Ventures Deep Acre +1 more

858 Therapeutics, Inc.8five8tx.comSeries A · May 2021 · $60M

858 Therapeutics is a clinical-stage biotechnology company developing targeted cancer therapies that act on tumor dependencies in DNA damage response (DDR) pathways.

BiotechHealthtechSan Diego, US

Stafford Jeffrey(Executive Officer, Director)inJames Veal(Executive Officer)Katherine Bell-McGuinn(Executive Officer)Joseph Leveque(Chief Medical Officer)

Board Monal Mehta(Director)in

Board seat Ali Behbahani· per SEC Form D

Co-investorsVersant Venture Capital Versant Ventures

Aigenaigen.io in 𝕏Seed · Aug 2025 · $12M

Aigen builds solar-powered autonomous field robots ("Element") that use AI vision to identify and mechanically remove weeds without chemicals.

AgTechAI & Machine LearningRoboticsSeattle, US

Richard Wurden(Co-founder)in Kenny Lee(Co-founder)in

BoardDan Fitzgerald(Director)Henry Magun(Director)

Board seat Andrew Schoen· per SEC Form D

Co-investorsCleveland Avenue Industrious Ventures AgFunder Global Founders Capital Incite.org ReGen Ventures

Akouosakouos.com inOct 2017 · $50M

Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing.

BiotechHealthtechBrookline, US

Emmanuel Simons(Executive Officer, Director)william sewell(Founder)in

Board Ed Mathers(Director)in Kush Parmar(Director)in

Board seat Edward Mathers· per SEC Form D

Co-investors5AM Ventures EcoR1 Capital Pivotal Life Sciences RA Capital Sofinnova Ventures Cowen Healthcare Investments +2 more

AppSheetappsheet.com inApr 2019 · $15M

AppSheet is a no-code application development platform that enables users to build apps and automated workflows without coding, using AI-powered tools and integrations with Google Workspace and third-party services.

Developer ToolsEnterprise SoftwareBellevue, US

Praveen Seshadri(President and Chief Executive Officer of the Issuer)

Board Ravi Mohan(Director of the Issuer)in

Board seat Greg Papadopoulos· per SEC Form D

Co-investorsTechstars Shasta Ventures

Aquabyte, Inc.aquabyte.noDec 2021

Aquabyte LUS is an AI-powered system that automatically counts sea lice in fish farms by analyzing camera images from fish enclosures, identifying different lice types and stages.

AgTechAI & Machine LearningFoodTechIoTSaaSSan Francisco, US

Bryton Shang(Executive Officer, Director, Promoter)

BoardGreg Sands(Director)Chandran Sankaran(Director)Sherman Li(Director)

Board seat Greg Papadopoulos· per SEC Form D

Arcellxarcellx.com inFeb 2022 · $115M

Arcellx develops CAR T-cell therapies that are individually designed for each patient, using the immune system to target and attack cancer.

BiotechHealthtechGaithersburg, US

Han Lee(Executive Officer)Rami Elghandour(Executive Officer, Director)in

Board Jill Carroll(Director)in Derek Yoon(Director)in Tiba Aynechi(Director)in

Board seat Kavita Patel Ali Behbahani· per SEC Form D

Co-investorsLG Technology Ventures Quan Capital Samsara BioCapital Sixty Degree Capital Solasta Ventures SR One Capital Management +5 more

Arkestroarkestro.com in 𝕏Series A · May 2022 · $26M

Arkestro provides intelligent procurement software that automates supplier quote collection and comparison for enterprise procurement teams.

AI & Machine LearningEnterprise SoftwareSaaSSan Francisco, US

Edmund Leiken Ben Leiken(Chief Product Officer (co-founder, originally CTO))in Rob Desantis(Chief Executive Officer and Co-Founder)inEdmund Adam Zagorin(Chief Strategy Officer and Co-Founder)Martin Meyer(Executive Officer)Neil Lustig(Executive Officer, Director)in

Board seat Jeff Immelt· per SEC Form D

Co-investorsActivant Capital Altira Group LLC Cervin Construct Capital El Cap Equity Forum Ventures +5 more

Automation Anywhereautomationanywhere.com in 𝕏Nov 2019

Automation Anywhere provides robotic process automation (RPA), intelligent document processing (IDP), and agentic automation solutions for enterprise customers.

AI & Machine LearningEnterprise SoftwareSaaSSan Jose, US

Mihir Shukla(Chairman & CEO)inNeeti Mehta Shukla(Director)inAnkur Kothari(Executive Officer, Director)inClyde Hosein(Executive Officer)in

BoardJohn Giannuzzi(Director)

Board seat Scott Sandell· per SEC Form D

Co-investors1435 Capital Collective Liquidity Eniac Ventures EQUIAM Firebolt Ventures Management Company, Llc Foothill Ventures +8 more

Belong Healthbelong-health.comDec 2025 · $40M

Belong Health provides a full-stack health plan operating platform and partnership model that helps organizations design and run health plans, sharing the risk of launching and building them.

Digital HealthHealthtechInsurTechSaaSRadnor, US

Douglas Duane Byrd(Executive Officer)

Board seatMohamad Makhzoumi· per SEC Form D

Co-investorsAlumni Ventures Bascom Ventures Blue Venture Funds Maverick Ventures Maverick Ventures Israel

Beyond Identitybeyondidentity.com in 𝕏Series A · Mar 2020 · $100M

Beyond Identity provides an authentication and identity platform built with security as the foundational design principle, eliminating passwords and validating both users and devices.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaSNew York, US

Louis Marascio in Nelson Melo inThomas Jermoluk(Executive Officer, Director)inJames Clark(Director)Jasson Casey(Founder)in Jasson Casey, PhD in

Board seat Hilarie Koplow-McAdams Forest Baskett· per SEC Form D

Co-investorsEvolution Equity Partners Koch Disruptive Technologies Evolution Technology Expanding Capital

Bitglassforcepoint.com in 𝕏Mar 2019

Forcepoint provides a data security platform that discovers, classifies, and protects sensitive data across cloud, web, endpoint, email, and network environments.

AI & Machine LearningCybersecurityEnterprise SoftwareCampbell, US

BALAS NATARAJAN KAUSIK(Co-Founder & Chief Executive Officer)ANURAG KAHOL(Co-Founder & Chief Technology Officer)inANOOP BHATTACHARJYA(Executive Officer)CHRISTOPHER CHAN(Executive Officer)inANDREW URUSHIMA(Executive Officer)RICH CAMPAGNA(Chief Marketing Officer)

Board seat Aaron Jacobson Scott Sandell Forest Baskett· per SEC Form D

Co-investorsAllegisCyber Capital Francisco Partners Javelin Venture Partners Norwest Venture Partners Samsung Catalyst Fund Scout Ventures +4 more

Built Roboticsbuiltrobotics.com in 𝕏Sep 2017 · $64M

Built Robotics develops autonomous robotics systems for solar energy installation, specifically for piling, trenching, and safety applications in solar farm construction.

CleantechConstruction TechEnergyHardwareRoboticsUnited States, US

Noah Ready-Campbell(Founder & CEO)in

Board seat Forest Baskett· per SEC Form D

Co-investorsBuilding Ventures Calibrate Ventures Great Oaks Venture Capital Next47 Perot Jain Valia Ventures +6 more

Burrowburrow.com in 𝕏Mar 2018Acquired

Burrow designs and sells modular furniture with an emphasis on quality, affordability, and fast delivery.

ConsumerE-commerceNew York City, US

Stephen Kuhl(Founder/CEO)in Kabeer Chopra(Founder)inSteven Finnern(Executive Officer)

Board seat Tony Florence· per SEC Form D

Co-investorsAlumni Ventures Amity Ventures Correlation Ventures FundersClub Multiplier Capital Passion Capital +17 more

Cardionomiccardionomicinc.comOct 2015

HealthtechForest Lake, US

Steve Goedeke(Executive Officer, Director)

BoardKaren Shanahan(Director)William Abraham(Director)Michael DeMane(Director)Jay Graf(Director)

Board seat Ali Behbahani· per SEC Form D

Co-investorsAscension Ventures NEA Secondary

Catalyticcatalytic.com 𝕏Jun 2018acquired by PagerDutySEC filingmedium confidence

PagerDuty Workflow Automation lets Dev and IT Operations teams automate manual business processes by combining human-in-the-loop steps such as approvals and decisions with technical automation like Runbook Automation.

Developer ToolsEnterprise SoftwareSaaSChicago, US

Sean Chou(Executive Officer, Director)inRavi Singh(Executive Officer, Director)

Board seatPeter Barris· per SEC Form D · $5.6M raise · filed Jul 2018

Co-investorsboldstart ventures Chicago Ventures In-Q-Tel Intel Capital Lightbank Valor Equity Partners +5 more

Cleo Labscleolabs.co in 𝕏Dec 2018SEC filingmedium confidence

Cleo provides software for compliance teams that automates regulatory monitoring and analysis while keeping human judgment central to decision-making.

AI & Machine LearningEnterprise SoftwareLegalTechSan Francisco, US

Shannon Spanhake(Executive Officer, Director)

BoardSarah Guo(Director)

Board seatVanessa Larco· per SEC Form D · $32.4M raise · filed Dec 2020

Co-investorsKima Ventures Accel Financière Saint James Premise Ventures

Coravincoravin.com in 𝕏Jun 2015SEC filingmedium confidence

Coravin makes a wine-preservation system that uses a thin needle and Argon gas to pour wine without removing the cork, keeping the remaining wine fresh for weeks to years.

ConsumerDirect to ConsumerHardwareBurlington, US

Greg Lambrecht(Executive Officer, Director)inGreg Lembrecht(Director)Frederic Levy(Executive Officer, Director)inNicholas Lazaris(Executive Officer, Director)Calli Prendergast(Executive Officer)in Dave Krupinski in

Board seatJoshua Makower· per SEC Form D · $15M raise · filed Jun 2015

Co-investorsAlpine Meridian Windham Capital Partners

Crowdboticscrowdbotics.com in 𝕏Oct 2022

Crowdbotics (now CoreStory) offers AI-based tools to analyze how existing software systems work, aimed at software modernization and maintenance.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareBerkeley, US

Anand Kulkarni(Executive Officer, Director)in

Board Hunter Walk(Director)in Victor Echevarria(Director)in

Board seat Aaron Jacobson· per SEC Form D

Co-investorsAlumni Ventures Bee Partners Jackson Square Ventures Nimble Partners Samsung Next Strawberry Creek Ventures +3 more

Curisiumcurisium.com inOct 2017 · $3.5M

Manhattan Beach, US

Peter Kim(Executive Officer, Director, Promoter)inFrancis Lam(Executive Officer, Director, Promoter)

Board Bill Geary(Director)in

Board seat Mohamad Makhzoumi· per SEC Form D

Co-investorsFlare Capital Partners Sanofi Ventures Green Bay Ventures Shuttle Fund

Datafolddatafold.com in 𝕏May 2025

Datafold builds AI-powered agents and tools that automate complex data engineering tasks including migrations, optimization, CI/CD, and data quality validation.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSNew York City, US

Gleb Mezhanskiy(Founder)inAlex Morozov(Founder)in

Board Peter Sonsini(Director)in

Board seat Aaron Jacobson· per SEC Form D

Co-investorsAmplify Partners Angel Collective Opportunity Fund Avant Labs BT Growth Capital Good News Ventures Hustle Fund +7 more

DataRobotdatarobot.com in 𝕏Oct 2020 · $270M

DataRobot develops an AI and machine learning platform that automates model development and deployment for enterprises.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareBoston, US

Jeremy Achin(Executive Officer, Director, Promoter)inTom de Godoy(Co-Founder and Former Chief Technology Officer)in

BoardHarry Weller(Director)Christopher Lynch(Director)in

Board seat Tony Florence Hilarie Koplow-McAdams· per SEC Form D

Co-investors515 Ventures Aliya Capital Partners AMK Investment Office B Capital Group B4 Capital Ballistic Ventures +43 more

Enigmaenigma.com in 𝕏Mar 2015

Enigma aggregates and analyzes public and third-party data to provide intelligence on the identity and financial health of small and medium businesses in the United States.

Data & InfrastructureEnterprise SoftwareFintechNew York, US

Hicham Oudghiri(Executive Officer, Director)Marc DaCosta(Executive Officer, Director)Jeremy Bronfman(Executive Officer, Director)

BoardBen Narasin(Director)Andrew Cleland(Director)in

Board seat Scott Sandell· per SEC Form D

Co-investorsComcast Ventures Crosslink Capital Expansion Venture Capital Glynn Capital Management Third Point Ventures Truist Ventures +3 more

Envisia Therapeuticsenvisiatherapeutics.com inOct 2015

Develops novel ocular therapies.

BiotechMorrisville, US

Ben Yerxa(Executive Officer)in Eric Linsley(Executive Officer)in

Board Ed Mathers(Director)in Stephen Bloch(Director)inSeth Rudnick(Director)inNeal Fowler(Director)

Board seat Edward Mathers· per SEC Form D

Co-investorsCanaan Partners Pappas Capital +ND Capital ARCH Venture Partners Illumina Ventures OMX Ventures

Everactiveeveractive.comSeries A · Sep 2020 · $5M

Everactive develops ultra-low power, self-powered systems-on-chip (SoCs) for Ambient IoT devices that sense, process, and wirelessly transmit data using harvested environmental energy instead of batteries.

HardwareIoTSemiconductorsSan Jose, US

Benton Calhoun(CEO and Co-Founder)inDavid Wentzloff(CTO and Co-Founder)inBrendan R Richardson(Executive Officer, Director)

BoardGeorge Kastendike(Director)Jack Busch(Director)

Board seat Greg Papadopoulos· per SEC Form D

Co-investorsAsahi Kasei Corporate Venture Capital Blue Bear Capital Partners OUP (Osage University Partners)ABB Technology Ventures Fluke Venture Partners GE Ventures +1 more

Evidentevidentid.com in 𝕏Apr 2019

Evident provides a platform to automate the exchange of risk data and optimize third-party risk management through due diligence and real-time monitoring of vendors, suppliers, service providers, and other third parties.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaSAlpharetta, US

David Thomas(Executive Officer, Director)in

Board seatVanessa Larco· per SEC Form D

Co-investorsAcrew Capital Alumni Ventures Aspect Ventures BLH Venture Partners, LLC Owl Capital Blue Cloud Ventures +1 more

Fabric8Labsfabric8labs.com inSeries B · Feb 2025 · $50M

Fabric8Labs develops Electrochemical Additive Manufacturing (ECAM), a room-temperature metal 3D printing technology that produces dense, high-purity metal parts with micron-scale resolution and no post-processing.

Advanced ManufacturingDeep TechHardwareSemiconductorsSan Diego, US

Jeffrey Herman(Executive Officer, Director)David Pain(Director)in

Board Cyril Vancura(Director)in Jennifer Ard(Director)in

Board seat Greg Papadopoulos· per SEC Form D

Co-investorsIntel Capital Lam Capital Marunouchi Innovation Partners SE Ventures TDK Ventures Ericsson Ventures +6 more

Firestormlaunchfirestorm.comSeries A · Feb 2026 · $82M

Firestorm Labs builds xCell, a containerized 3D-printing factory that produces modular military drones at the point of need.

San Diego, US

Daniel Magy(Executive Officer, Director, Promoter)Chad McCoy(Founder)inIan Muceus(Founder)in

BoardTommy Hendrix(Director)

Board seat Aaron Jacobson· per SEC Form D

Co-investorsAlumni Ventures Backswing Ventures Beyond Capital Black Flag Booz Allen Ventures BVVC +18 more

ForAllSecureforallsecure.com in 𝕏Nov 2018SEC filingmedium confidence

Mayhem provides AI-powered fuzzing and symbolic execution tools for vulnerability discovery and API testing, designed to reduce noise in software supply chain assessments for development teams.

AI & Machine LearningCybersecurityDeveloper ToolsPittsburgh, US

David Brumley(Executive Officer, Director)inAlexandre Rebert(Cofounder)Tiffany To(Executive Officer, Director)

Board seat Aaron Jacobson· per SEC Form D · $15M raise · filed Mar 2019

Co-investorsKoch Disruptive Technologies Presidio Ventures

Genocea Biosciences inJul 2020SEC filingmedium confidence

Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.

BiotechCambridge, US

Narinder Singh(Executive Officer)Derek Meisner(Executive Officer)inMichael Alfieri(Executive Officer)Jessica Flechtner(Executive Officer)Girish Aakalu(Executive Officer)Thomas Davis(Executive Officer)

Board seat Ali Behbahani· per SEC Form D · $79.9M raise · filed Aug 2020

Co-investorsCycad Group LLC Lux Capital MC Healthcare Ventures Advent Life Sciences Alexandria Auriga Partners +1 more

Getwellnetwork Incgetwellnetwork.com in 𝕏Jul 2016

Get Well provides patient and family engagement technology for healthcare providers, now combined with RhythmX AI to bring AI capabilities to its offerings.

AI & Machine LearningDigital HealthHealthtechSaaSCambridge, US

Michael O'Neil(Founder & CEO)inDeepthi Bathina(Founder & CEO, GW RhythmX (Get Well + RhythmX AI))inPaul Roscoe(President, Treasurer, Secretary and Director of Issuer)Nathan Gnanasambandam(Chief AI Officer)inTim Kostner(Chief Revenue Officer)in

BoardTrevor Price(Director)

Board seat Mohamad Makhzoumi· per SEC Form D

Co-investorsAscension Ventures PJC

Green Chefgreenchef.comMar 2015

Green Chef is a meal-kit service that delivers pre-portioned ingredients and recipes developed by chefs and registered dietitians, with nutrition labels and dietary options for consumers seeking balanced, health-conscious meals.

ConsumerDirect to ConsumerFoodTechWellness & FitnessDenver, US

MICHAEL JOSEPH(Executive Officer, Director)

BoardDAN YUE(Director)

Board seat Scott Sandell· per SEC Form D

Co-investorsFJ Labs

Hillcrest Laboratories inNov 2016

Rockville, US

Daniel Simpkins(Executive Officer, Director)Peter Jackson(Executive Officer)inChuck Gritton(Executive Officer)

BoardFrank Adams(Director)R. Philip Herget(Director)

Board seat Patrick Kerins· per SEC Form D

Horizon3 Aihorizon3.ai in 𝕏May 2025

Horizon3.ai builds cybersecurity products and solutions.

AI & Machine LearningCybersecurityEnterprise SoftwareSan Francisco, US

Snehal Antani(Co-Founder, CEO)inMatthew Hartley in Anthony Pillitiere(Co-Founder)in

Board Ilya Kirnos(Director)in Michael Robinson(Director)in

Board seat Lila Tretikov· per SEC Form D

Co-investorsAcrew Capital Craft Ventures NewView Capital NightDragon Qualcomm Ventures Raptor Group +3 more

Illumitexillumitex.com inApr 2015

Austin, US

Chris Hammelef(President)inCarl Gallagher(Secretary and CFO)inDung T. Duong(Executive Officer, Director)inMatthew R. Thomas(Executive Officer, Director)Randall E. Johnson(Executive Officer)in

BoardArmando Pauker(Director)

Board seat Forest Baskett· per SEC Form D

Co-investorsWP Global Partners Mercury Fund Morgan Creek Capital WP Explorer

Intrinsic Therapeuticsbarricaid.com in 𝕏Dec 2016

Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects.

HealthtechMedical DevicesWoburn, US

Gregory H. Lambrecht(Director)Carey Hagan(Executive Officer, Director)Cary Hagan(Executive Officer, Director)

Board Ryan Drant(Director)inJeani Delagardelle(Director)

Board seatJoshua MakowerJoshua H Makower· per SEC Form D

Co-investorsDelos Capital Questa Capital Greenspring Associates New Leaf Venture Partners

Ivantis Incivantisinc.comJan 2017Acquired

Ivantis was a medical device company founded in 2007 in Irvine, California, that developed the Hydrus Microstent, a minimally invasive device for treating glaucoma during cataract surgery.

Irvine, US

David Van Meter(Executive Officer, Director)

BoardTara Butler(Director)Douglas Roeder(Director)Randy Alexander(Director)Thong Yuen Poon(Director)

Board seat Ali Behbahani· per SEC Form D

Co-investorsAscension Ventures Foresite Capital RA Capital MemorialCare Innovation Fund

Kindredlivekindred.com in 𝕏Dec 2022

Kindred is a platform that facilitates home swaps between travelers, connecting people who exchange their homes for periods of time.

MarketplacesTravel & HospitalitySan Francisco, US

Justine Palefsky(Founder)inTasneem Amina(Founder)in

Board seatVanessa Larco· per SEC Form D

Co-investorsAndreessen Horowitz Asymmetric Capital Partners Avenir Growth Capital Bessemer Venture Partners BoxGroup Caffeinated Capital +3 more

Luminary Medialuminarypodcasts.comMar 2018 · $40M

Luminary was a podcast service offering access to a catalog of podcasts through its own app.

Media & EntertainmentChicago, US

Matthew S. Sacks(Executive Officer, Director)Simon Sutton(Executive Officer, Director)

BoardMichael J. Sacks(Director)Tony S. Florence(Director)inAlejandro Zubillaga(Director)Richard Plepler(Director)

Board seat Tony Florence· per SEC Form D

Co-investorsValor Equity Partners

Maisonettemaisonette.com 𝕏May 2018 · $30M

Maisonette is an online retail platform selling children's products, including apparel, backpacks, school supplies, and organization essentials for kids of various ages.

ConsumerE-commerceMarketplacesBrooklyn, US

Sylvana Durrett(Executive Officer, Director, Promoter)inLuisa Mendoza(Executive Officer, Director, Promoter)in

Board seat Tony Florence· per SEC Form D

Co-investorsAlumni Ventures Angel Capital Management Fernbrook Capital Management G Squared Ingeborg Investments SNAK Venture Partners +3 more

Metalenzmetalenz.com in 𝕏Sep 2022SEC filingmedium confidence

Metalenz develops metasurface optics technology for optical sensing in consumer and industrial devices.

Deep TechHardwareSemiconductorsStoneham, US

Federico Capasso(Co-founder)in Rob Devlin(Co-Founder and CEO)in

Board Xuhui Shao(Director)in

Board seatKrishna Swaroop Kolluri· per SEC Form D · $29M raise · filed Oct 2022

Co-investorsBantam Group Braemar Energy Ventures Foothill Ventures Global Brain Intel Capital M Ventures +7 more

Minerva Surgicalminervasurgical.com inDec 2015

Minerva Surgical is a women's health medical device company focused on technologies for conditions such as heavy menstrual bleeding, offering alternatives to hysterectomy.

FemTechHealthtechMedical DevicesRedwood City, US

Csaba Truckai(Director)Dr. Geiger(Board Member / Founder of Accelmed)David Clapper(Executive Officer, Director)inDarin(CEO)

BoardRoss Jaffe(Director)

Board seat Ali Behbahani· per SEC Form D

Moviusmovius.ai in 𝕏Jun 2017 · $45M

Movius provides MultiLine, a mobile-first platform for secure, compliant business voice calling, SMS, social messaging, and Microsoft Teams communication delivered as Secure Communication as a Service (SCaaS).

AI & Machine LearningEnterprise SoftwareSaaSDuluth, US

Craig Hasek(Executive Officer)inAnanth Siva(Chief Executive Officer)in Rick Martig(Chief Operating & Financial Officer)inAmit Modi(Chief Technology Officer, CISO & Evangelist)Chethan Visweswar(Chief Product Officer)inAjay Thakur(Chief Information Officer)in

Board seatRichard Kramlich· per SEC Form D

Co-investorsPointguard Ventures Battery Ventures JP Morgan Chase

Moximedmoximed.comSeed · Aug 2024

HealthtechFremont, US

Anton Clifford(Executive Officer)in James Leech(Executive Officer)in Christopher Gleason(Executive Officer)inKevin K. Sidow(Executive Officer, Director)

Board Shahzad Malik(Director)in

Board seatJoshua Makower· per SEC Form D

Co-investorsLightstone Ventures Runway Growth Capital Advent Life Sciences GBS Venture Partners Ltd.Gilde Healthcare Vertex Ventures HC

Narminarmi.com in 𝕏Series A · May 2022 · $20M

Narmi provides digital banking technology and tools to community banks and credit unions, enabling them to compete with larger financial institutions.

FintechSaaSNew York City, US

Nikhil Lakhanpal(Co-Founder and Co-President)in Chris Griffin(Co-Founder and Co-President)inSean Gray(COO & President)

BoardJill Castilla(CEO & President)

Board seatLiza Landsman· per SEC Form D

Co-investorsContour Venture Partners FiDi Ventures Greycroft Patriot Financial Partners PICUS CAPITAL Techstars

NODARnodarsensor.com in 𝕏Series A · Feb 2026 · $12M

NODAR develops stereo-vision technology that uses patented algorithms with standard cameras to produce long-range, high-precision 3D spatial data.

AI & Machine LearningDeep TechHardwareMobility & TransportationRoboticsConcord, US

Leaf Jiang(Founder)in

Board Carsten Boers(Director)inRoger Nielsen(Director)in

Board seat Greg Papadopoulos· per SEC Form D

Co-investorsRhapsody Venture Partners

Outrider Technologiesoutrider.ai in 𝕏Apr 2026

Outrider develops automated yard operations technology for supply chain logistics, focusing on improving efficiency, safety, and sustainability through autonomous equipment and yard management systems.

CleantechLogistics & Supply ChainRoboticsBrighton, US

Andrew F. Smith(Executive Officer, Director, Promoter)inRobert Hall(Executive Officer)Paul Sung Cha(Executive Officer)in

BoardByron Knight(Director)Mark Norman(Director)in

Board seat Aaron Jacobson· per SEC Form D

Co-investors8VC Fraser McCombs Capital Interwoven Ventures Koch Disruptive Technologies Loup Ventures Presidio Ventures +4 more

Oyster Point Pharma, Inc.oysterpointrx.com 𝕏Oct 2017

A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.

BiotechHealthtechSan Francisco, US

Jeffrey Nau(Executive Officer, Director)inMark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)

BoardWilliam J Link(Director)

Board seat Ali Behbahani· per SEC Form D

Co-investorsFlying L Partners Versant Venture AIV Holdings Versant Ventures Vida Ventures

Pacific Light & Hologrampacificlightandhologram.comApr 2019

A tech startup operating in stealth mode on an undisclosed vision; it has developed Veluminum, a matte, velvet-like coating for aluminum.

Deep TechHardwareNew MaterialsSouth Pasadena, US

Asher Zelig Sefami(Founder)inJonathan Seamus Blackley(Executive Officer, Director)

Board Gregory Papadopoulos(Director)in

Board seat Forest Baskett· per SEC Form D

Co-investorsCambium Capital M Ventures Metaplanet

Pathospathos.com inSeries C · May 2025 · $62M

Pathos applies AI, biological modeling, and a large collection of multimodal oncology patient data to develop cancer drugs and accelerate clinical development.

AI & Machine LearningBiotechDigital HealthHealthtechChicago, US

Eric Lefkofky(Executive Officer, Director)Eric Lefkofsky(Co-founder)in Ryan Fukushima(Co-founder)inAndrew Heinlein(Executive Officer)Alex Dolan(Executive Officer)in Iker Huerga(Chief Executive Officer and Board Member)in

Board seatMohamad Makhzoumi· per SEC Form D

Co-investorsCota Capital Lightbank Lingotto

PayZenpayzen.com in 𝕏Series B · Sep 2024 · $32M

PayZen provides AI-powered, interest-free patient financing that lets patients pay medical bills over time through personalized payment plans, with pre-built EHR integrations and automated servicing for providers.

AI & Machine LearningDigital HealthFintechHealthtechSan Francisco, US

Tobias Mezger(Executive Officer, Director)inIsaac Cohen(Executive Officer, Director)Ariel Rosenthal(Co-Founder & CTO)in Itzik Cohen(Co-Founder & CEO)inAntonio Martino(Executive Officer)in

Board Lee Shapiro(Director)in

Board seatMohamad Makhzoumi· per SEC Form D

Co-investors7wire Ventures SignalFire Corewell Health Ventures Haymaker Ventures Link Ventures Lorimer Ventures +4 more

Placesterplacester.com inNov 2015

Marketing TechPropTechBoston, US

Frederick Townes(Director)in Matt Barba(Founder)in

BoardDavid Anderson(Director)Krishna Gupta(Director)in

Board seatRavi Viswanathan· per SEC Form D

Co-investorsREMUS Capital Techstars Benchmark Romulus Capital

Pulumipulumi.com in 𝕏Series B · Oct 2020 · $38M

Pulumi provides Infrastructure as Code tools using general-purpose languages to help engineers build and manage cloud infrastructure faster.

Cloud ComputingDeveloper ToolsEnterprise SoftwareSeattle, US

John Joseph Duffy(Executive Officer, Director)Eric Rudder(Founder)in Joe Duffy(Founder)in

Board Sheila Gulati(Director)in"S. ""Soma""" Somasegar(Director)

Board seat Aaron Jacobson· per SEC Form D

Co-investorsFirebolt Ventures Management Company, Llc Madrona Venture Group Tola Capital Strike Capital

Qadiumqadium.comMay 2016

San Francisco, US

Tim Junio(Executive Officer)Matthew Kraning(Executive Officer, Director)Joseph Meyerowitz(Executive Officer, Director)Shaun Maguire(Director)

Board seat Scott Sandell· per SEC Form D

Co-investorsFounders Fund IVP (Institutional Venture Partners)Susa Ventures

Qualified Healthqualifiedhealthai.com inJul 2026

Qualified Health AI provides AI infrastructure and governance solutions for health systems to deploy generative AI safely and deliver measurable value across clinical, operational, and financial workflows.

AI & Machine LearningDigital HealthHealthtechSan Carlos, US

Justin Norden(Founder & CEO)in Kedar Mate(Co-Founder & Chief Medical Officer)in Shantanu Phatakwala in Beau Norgeot in

Board Sooah Cho(Director)in

Board seat Mohamad Makhzoumi· per SEC Form D

Co-investorsHealthier Capital Cathay Innovation Flare Capital Partners Frist Cressey Ventures GreatPoint Ventures Menlo Ventures +3 more

Radiology Partnersradpartners.com in 𝕏Seed · Jun 2026

Radiology Partners is a physician-led national radiology practice that provides diagnostic imaging services and develops AI tools and technology to support radiologists in delivering patient care.

AI & Machine LearningDigital HealthHealthtechMedical DevicesNashville, US

Anthony Gabriel(Executive Officer, Promoter)inRich Whitney(CEO and Co-founder)in John Pantazis(Executive Officer)inJamie Larsen(Executive Officer)Krishna Nallamshetty(Executive Officer)inVijay Vaidya(Executive Officer)in

Board seat Mohamad Makhzoumi Kavita Patel· per SEC Form D

Co-investorsHeritage Group Whistler Capital Partners Questa Capital

Rhythm Pharmaceuticalsrhythmtx.com in 𝕏Aug 2015

Rhythm Therapeutics develops precision medicines for rare neuroendocrine diseases, particularly those affecting the melanocortin-4 receptor pathway.

BiotechDigital HealthHealthtechMedical DevicesBoston, US

Keith Gottesdiener(Executive Officer, Director)in Bart Henderson(Mr. Henderson is the President and Treasurer of the Issuer.)inDavid Meeker(President and Chief Executive Officer)in

Board Jonathan Silverstein(Director)in Neil Exter(Director)in

Board seatEdward T. Mathers· per SEC Form D

Co-investorsForesite Capital HEALTHCARE ROYALTY PARTNERS Pfizer Venture Investments OrbiMed Third Rock Ventures

Rotation Medicalrotationmedical.comJul 2016

HealthtechPlymouth, US

Thomas Westling(Executive Officer, Director)inMartha Shadan(Executive Officer, Director)Randy Nuernberg(Executive Officer)Craig Van Kampen(Executive Officer)

Board Fouad Azzam(Director)inScott Weiner(Director)in

Board seat Ali Behbahani· per SEC Form D

Co-investorsPappas Capital LSP (Life Sciences Partners)Pappas Capital

Science Logicsciencelogic.com in 𝕏Feb 2015

ScienceLogic offers an AI-driven IT operations platform that discovers, monitors, and automates actions across hybrid IT environments.

AI & Machine LearningCloud ComputingEnterprise SoftwareSaaSReston, US

David F. Link(Executive Officer, Director)in Richard Chart(Executive Officer)in Dave Link(Founder and CEO)in David Link(Executive Officer, Director, Promoter)inPatrick McCoy(Executive Officer)

BoardDavid Campbell(Board Member (Managing Director, Goldman Sachs & Co))

Board seatHarry Weller· per SEC Form D

Co-investorsIntel Capital NewView Capital Savano Capital Partners

Second Front Systemssecondfront.com in 𝕏Series B · Nov 2023 · $40M

Second Front delivers software solutions to government and allied democracies to accelerate access to emerging technologies.

Defense TechDeveloper ToolsGovTechSaaSArlington, US

Peter Dixon(Chief Executive Officer)in Tyler Sweatt(Founder)inMark Butler(President)in

BoardAlberto Yepez(Director)Austin Walne(Director)inPeter Pace(Director)

Board seat Aaron Jacobson· per SEC Form D

Co-investors137 Ventures Abstract Ventures Artis Ventures Battery Ventures Boeing HorizonX Ventures Booz Allen Ventures +6 more

Sportsrocket inJul 2015 · $15M

New York sports media company that builds and operates customized OTT platforms for leagues, publishers and rights-holders.

New York, US

Joseph Brady(Executive Officer)inBrian Bedol(Executive Officer, Director)in

BoardBrian Hermelin(Director)inJames Pallotta(Director)Kenneth Lerer(Director)

Board seat Patrick Kerins· per SEC Form D

Co-investorsCourtside Ventures M13

Spring Globalspringglobal.com in 𝕏Series C · Dec 2016 · $66M

Spring is an AI-native field intelligence platform for consumer packaged goods (CPG) companies that multiplies field team capacity through coaching, agents, and intelligent tools without requiring headcount scaling.

AgTechAI & Machine LearningEnterprise SoftwareSaaSReston, US

Tommy Bittner(Chief Executive Officer)in Kevin G. Lee(Executive Officer)in

BoardJustin Burden(Director)Patrick J. Kerins(Director)inRogerio Fava(Director)Conor Keane(Board Member)

Board seat Patrick Kerins· per SEC Form D

Co-investorsSapphire Ventures Savano Capital Partners

Streamgetstream.io in 𝕏Aug 2020SEC filingmedium confidence

Stream provides infrastructure for building AI applications and real-time communication features including chat, video, feed, and moderation across multiple platforms.

AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareBoulder, US

Thierry Schellenbach(Founder)in Tommaso Barbugli(Executive Officer, Director)in

BoardJohn Ives(Director)

Board seat Tiffany Luck· per SEC Form D · $30.4M raise · filed Mar 2021

Co-investorsTechstars Felicis Ventures Social Starts Upslope Ventures UpVentures Capital V1 VC +9 more

Tamara Mellon Brandtamaramellon.comFeb 2016

West Hollywood, US

Tamara Mellon(Executive Officer, Director)Jill Layfield(Executive Officer, Director)

BoardMichael Ovitz(Director)

Board seat Tony Florence· per SEC Form D

Co-investorsAAF Management Ltd.GPIH Quadrille Capital

Tesarogsk.com in 𝕏Apr 2016

GSK is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients.

BiotechHealthtechLondon, GB

Mary Lynne Hedley(Executive Officer, Director)Leon O. Moulder, Jr.(Executive Officer, Director)Jeffrey Hanke(Executive Officer)Joseph L. Farmer(Executive Officer)inGrant C. Bogle(Executive Officer)Martin H. Huber(Executive Officer)

Board seatDavid Mott Kavita Patel· per SEC Form D

Co-investorsKleiner Perkins Pappas Capital Ridgeback Capital Avoro Capital Advisors

ThreatQuotientthreatq.com in 𝕏Aug 2016

ThreatQ is a threat intelligence platform that aggregates, analyzes, and acts on threat data across security infrastructure for organizations.

CybersecurityData & InfrastructureEnterprise SoftwareSterling, US

WAYNE CHIANG(CHIEF ARCHITECT)inRYAN TROST(CHIEF TECHNOLOGY OFFICER)in JOHN CZUPAK(PRESIDENT AND CHIEF EXECUTIVE OFFICER)inLEONARD P. KURTZMAN(CHIEF FINANCIAL OFFICER, SECRETARY AND TREASURER)

BoardSTEVEN CHEN(Director)

Board seatHarry WellerPeter Barris· per SEC Form D

Co-investorsCisco Investments Escalate Capital Partners Flucas Ventures Kube VC NTT DOCOMO Ventures Ossian Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Aptive Systems Araz Aset Therapeutics Branch Metrics, Inc.Bright HealthComplexaCRISPR TherapeuticsCurzion Pharmaceuticals Inc Cydan II EBH Holding ExploraMed NC7 FirstLight Bio, Inc.Flow CommerceGoEuroLaunchpad Therapeutics, Inc.Nexo Therapeutics, Inc.Nusantara HoldingsOne ConcernOnfido LtdRetrieve TechnologiesRocket.Chat Holdings, Ltd.SiteTraker Snagfilms Solace Therapeutics Stable Coin Inc.Tectus

Browse all 1,155 investments with full details →

▶955 more tracked companies

Tiger Data Toloka Group Travelator Tulip Tune Therapeutics Twelve Labs UniphoreVirgin PulseVori Health Waltz Networks Waymark Wizard Commerce Wonder Group X9, Inc.ZeroFox (NYSE: 2022)011BOG222 23andme3Com Corporation3ware42Floors 43 51offer Acadia PharmaceuticalsAcclarentAciexAcquia Acrivon Therapeutics Actions Semiconductor Co., Ltd.AddThisAdvanced CardiovascularAeluros Aera Aerohive Networks Aerospike AetionAffimedAffinia Therapeutics AI Fund AI Squared Air WorksAjax Vascular, Inc.Alcon Alexza PharmaceuticalsAlfredAlfredAlienVaultAlimerasciencesAllakos Inc Allay Therapeutics Alteon Websystems Amber Therapeutics American Pathology PartnersAmerigroup CorporationAmicus TherapeuticsAMISYS Managed CareAmplyx Amplyx PharmaceuticalsAnacorAneuRxAnnexon Anterior Antimatter Antimatter Antimatter Anyscale AnywhereAnywhereAppian Applix ApprendaAppriva MedicalAquabyte Aquantia Archie ArdelyxArgon NetworksARRIS CompositesAscend CommunicationsAstral PointAtheros CommunicationsAthira Atrium AttestAudienceAugust Aurelian Aurinia Pharmaceuticals Availink Avenzo AVEO Oncology AviadoBio Backflip Backflip AI Baihe Holding Corporation Barkly Protects Basalt Basalt HealthBay Networks (Wellfleet Comm)BCD SemiconductorBeachMintBedRocket Mediabeehiiv Belly BenchPrepBerkeley NetworksBerkshire Grey BestowBethesda Research LabsBig Data FederationBlack Duck Blacktag Bliq Block Renovation BlockCypher Blockchain web services Bloomreach, Inc.Blue CheetahBlue Jeans NetworkBlue OceanBlue Shift Labs Bluefish BNTO BNTO Boingo Wireless BokuBonsaiBoxcar Braintree Branch Branch Brandless Bravo Health Brenig Therapeutics, Inc.Bright Health Group Brightkite BroadlyBroadview Network HoldingsBytedanceCadence PharmaceuticalsCandy Digital Canopy Canopy TaxCardioThoracic SystemsCardiovascular Imaging SystemsCardurionCardurion PharmaceuticalsCare.com CareerBuilder CarezoneCarrier Access CorporationCarticept MedicalCartivaCascadian Therapeutics Casper Casper Casper's Catalog CatalogCatalystbiosciencesCathay Industrial Biotech, Ltd.Causes CCP Games Centralize Centrexion Therapeutics Ceramic AI Cerecor Inc.Channeladvisor CHAOS Charm Charm Charm CHARM Therapeutics Chelsio Communications CHG HealthcareChina Gtel LimitedChina Health (CITIC)ChromaCodeCirrus LogicCistaClarifaiClarifyClarVista Medical ClearMetal ClearMotion Clearspring Technologies Cleave Biosciences ClementiaCleversafeClioClockwork SystemsCloudflare Clovis Oncology Coda Code 42 Code BiotherapeuticsCoEditionCogenesysCollective HealthCom21ComancheComanche Biopharma Compass Labs Comprehensive Pharmacy ServicesConceptusContra Conviva Corca CorcaCorvisCorxel Cotopaxi Courtyard Courtyard.io Cowboy Space CorporationCrewLABCRISPR CrowdMedCTI BiopharmaCuralate Curana Health Curisium Cusp AiCV IngenuityCV Therapeutics CventCyberMediaCyenceCyras SystemsDallas SemiconductorDandelion EnergyData DomainDatabento Databricks DatriumDaVita NephrolifeDecruDeltaStream Dermira Desire2Learn Desktop MetalDevices for Vascular InterventionDevyce Diamond TherapeuticsDiatideDidi Divvy Divvy Divvy Djust DocentDOTS Technology CorpDroboDropDropDrop DropDSI RenalDura PharmaceuticalsE*OfferingE2O CommunicationsEargo EarlenseBenxEcho Global Logistics EchodyneEchopass CorporationECI Acquisition HoldingseConvergentEdelman Financial Engines Edmodo Eko Health Element3 Health ElevenLabs Elion Embrace EmbraceEmbraneEnceladusEnceladus BioEndocardial SolutionsEndotexEngine YardEnginesEnzytechEpix TherapeuticseRoomErytech PharmaEscient PharmaceuticalsESP PharmaEsprit PharmaEucalyptus SystemsEuclid AnalyticsEvalveEvenly EventUp EverFi Evernote Evernow Everside Everside HealthExent TechnologiesExpanse ExpelExploraMedFabFitFun Factory Factory Factory Fanhattan Fanhouse Fastino Feather Fenris GamesFibexFieldglassFiftyThree FightCamp Financial Software & SystemsFineground NetworksFIRE1 Firebase First CryFisker AutomotiveFizz Flow Flow Flow Flow Flow Flow Flow48 Flutter Folloze Forerunner Foresight Forethought Technologies, Inc.Formlabs ForterFox Hollow TechnologiesFramebridge Freo Freshplum Friskai Frontier Car Group FTXFTX USFugueFulcrum MicrosystemsFunctional Finance Fusion I/O FusionOps Fyusion Gaikai Gainspeed Galera Therapeutics GeistMGeltex PharmaceuticalsGen.GGenetic Therapy Inc.Genies Genmo GeoTel CorporationGilt GroupeGlacier Glacier Gladly Gladly Glamsquad Global Savings Group GlobalLogic Gloucester Pharmaceuticals GLU Mobile Glycomimetics GOAT GOAT GroupGoji SolutionsGolden Analytics Golden State Medical SupplyGoodGuideGoodLeap Goody Goop GraftGrand JunctionGraphite SystemsGravel Great Jones Greenlight GreoGrey RhinoGreycroft greytHR GridPointGrowth NetworksGuardentGuideline GuideSpark GumGumGynecareH2Corporation Habitat Health Hackerone Hannun Healthsouth HeapHearsayHeavyHemoSense Hired Hireguide HockeyStackHorizon Therapeuticshos House Rx Houzz Howl Hydra BiosciencesHYGEIA Medical Services GroupHyperfair Hyperion Therapeutics Idfy IfOnly IFTTT Igneous Igneous Systems IIX illusive networks iManage ImmigramImmunex CorporationIn House In-House HealthIncareyIndioInfinity PharmaceuticalsInfluitive CorporationInfoGear TechnologyInfoworksInhibitexInkitt InnerWorkings Inozyme Pharma InporiaInSoftInstabase Intact Vascular Intact VascularIntarcia TherapeuticsIntelligenceNODEIntellisysIntrinsic Inventiva InversagoIomai CorporationIOpipe ISGN Technologies Ltd.Jet.com Jomboy Media Juniper Networks Juvo Jyve Kaazing Kaizen Kaizen Labs KeelvarKetraKhoros(formerly Lithium Technologies)Kindred Kira Kira KISWE Knotch Koala Kong KONUXKoudaiKumuKumu NetworksLandit Landit Latitude Latitude Lattice EnginesLaurel NetworksLayer LearnUp Ledge LedgyLegato MedicalLemonade LeonaBioLetgoLianLianLife TechnologiesLily AI LimitlessLinekong International Co., Ltd.Lithium Little LabsLiveLoopLiza HealthLizzy Ai Logikcull Long Term Care Group Loopt Lore Lore Loxo Oncology Lumena Luminal Luminary MicroLuminate WirelessLumos Pharma Lungpacer MedicalLXAMage Legal Magenta Medical Mainstream Data MaintainX MapD Technologies Marathon Health Marketo Martian Mashgin Master Class Matroid Mattermark Mayhem Security MBX BiosciencesMediaoceanMediSys EduTech MEI Pharma mejuri story Merge MergeMerlinMersana Therapeutics Metabase Metacrine Metavention Metromilemi|imMicro Focus Mighty AI Mighty AI Millennial Media Mimosa Networks Inc Mindee MindTickle MinimumMission Critical SoftwareMissMalini MobiSocialMobius Management SystemsModa Operandi Modyfi Mojo Vision Moonpay More HealthMotion ComputingMotricityMotus TherapeuticsMovius Interactive CorporationMulesoftMyFitMyogenNaaptol Naked Labs NamespaceNationwide Remittance CentersNefeli NetworksNellcorNeo CyberneticaNeoterisNeoTractNetSolveNeueHealth Neural Magic Neuralieve Neutral Tandem NevroNew Globe EducationNEW WAVENew Wave FoodsnewScaleNexchemNexImmuneNext Power 360NG.CASH NginxNiaraNiciraNightstarNimble Collective Nimble Storage NinjaOne Nitra Node Node Noonlight NordsenseNova FertilityNovaceptNovast Holdings LimitedNovatiumNth RoundNuelleNuvolo OANDA ObsEva OhaiOmioOmthera Pharmaceuticals OnshapeOnStreamOrbis Medicines Orby AI Orexigen TherapeuticsOrigin MedsystemsOrphoMed Ouro Medicines OzonePacketeerPager Pair Eyewear Panacea Medical Technologies PantheonParc PlacePatientKeeper PatreonPcOrderPegasystems Pentaho Pentaho Peplin Perplexity Personal Genome DiagnosticsPharmionPhaseBio Pharmaceuticals Phathom Pharmaceuticals Philo Physical Intelligence Picaboo PILOT AI LABS, INC.Pinnacle EnginesPionyr Immunotherapeutics PixieBrixPlacemeterPlaidPlatoPlay Versus Inc.Playdom Players Tribune PlayVS Pluribus NetworksPlusmoPocketPolyservePomello Popai Poppy Handcrafted PopcornPortAuthorityppoNEXTPredictive Biosciences Prelay Prime Financial Technologies Procket Progress Software Proofoflearn Propense AIProsensaProteostasis TherapeuticsProxima TherapeuticsPsyadon PharmaceuticalsPulsePure EnergiesPyxisQpex Biopharma QualifiedQuantum Bridge CommunicationsQuidsi (Diapers.com)Quill QuoteWell Ra PharmaceuticalsRaiseRapid RoboticsRavelReachifyRecludixRedbabyRefresh Club Regression Games Regulus Regulus Therapeutics Inc.Relay Ventures Relievant Medsystems Reltio Reneo Reneo Pharmaceuticals ResilienceRetrieveRevelio Revelle Aesthetics RevSpring Rewind AI RF Monolithics Rf Surgical Rigel PharmaceuticalsRingCubeRock HealthRocket Rocket Runtime Rx Redefined SafeBase SafeRide Health SafeTrek Sakana AISalixSamaya AI Sana Labs Sapho Sasken Communications Satori PharmaceuticalsSavara PharmaceuticalsSave SAY Media SBCSCI SolutionsScopely, Inc.Scout RFP Scoutible Scratch Music Group SegmentSemiconductor Manufacturing International Corporation (SMIC)SengledSentons Sentry SepracorSeragon PharmaceuticalsSerious EnergySierra AtlanticSilicon Blue TechnologiesSilicon SpiceSimple HabitSimple PsychologySimpleRoseSimplex HealthcareSimsolid SingleStore Singularity Sisu Sisu Data SitetrackerSiTimeSiTime Corporation （米国）Slash Sleep Reset Slope Slope SmartDrive Systems, Inc.SnowplowSocialRadarSolar JunctionSolidFire Solta Medical Some Spider Studios Sonatype Sonic Innovations Sora Schools SORAA Sourcefire Sourcery.AISpectrianSpektr SpinewaveSpirationSplice Bio SpoknSpreadtrum CommunicationsSpringpathSprout Stablix Starcity Stash StemcentrxStormpathStreamSets Stride Health Strive HealthStrongbridge BiopharmaSubtext SugarAI SugarCRMSun EdisonSunDeckSuperSuperGenSupernus PharmaceuticalsSupplyBaseSurface OncologySurgical HealthSurgRxSwift Navigation SwiftypeSwirldsSwitchOn NetworksSyllable SynthesiaTableauTableau SoftwareTabula Tabula Tagkast Tagworks Pharmaceuticals Tailor Tamr Tarveda Therapeutics Teal DronesTechnical CommunitiesTele AtlasTelebit CorpTelegent SystemsTempest TherapeuticsTenerosTeracentTestMartThankful The Climate Corporation The Foundry The Players Tribune The Well The Wing The WingThe YesTheorycraft GamesTherachonThirdLove Thunkable Tiburio Therapeutics Tidal Therapeutics TidemarkTiger Data (creators of TimescaleDB)Tigera TintriTivoTogether AI Tokenz Topera Topia TrackMaven TRACON Pharmaceuticals TractTrading DynamicsTranscept PharmaceuticalsTransfix TransifexTranslucentTranslucent AITransvascularTravelbank Trevena Trillium TherapeuticsTripodtriValence TrivascularTuriTwelveTwenty (YC S23)U First Capital U S Renal CareUhanaUlinkUltheraUltraDNSUnbound SecurityUnifyIDUnion Upskill Upworthy Ursa Space SystemsUUNETValley SteerValleysteer ValueFirstVantage OncologyVAST DataVenmoVerona PharmaVertex PharmaceuticalsVerticaVertiFlex VezaViddyVideologyVimaan RoboticsViracta Therapeutics (formerly Sunesis)VirataVirtela Virtru VishwaVitesse SemiconductorVividCortexVixs SystemsVizbeeVocalocityVtesseVuclip VytronUS Wallapop WaymarkWebExWebEx CommunicationsWebMD (Healtheon)Welltok Wheelhouse Wheelhouse Wheels Wheels UpWiiTHWillow Willow WireWheel Wispr Flow Wit.AI WizardWNP CommunicationsWoebot Woebot Health Workera World Labs Xaira TherapeuticsXcelXfire Xoc Pharmaceuticals Xoom CorporationXrosXsky Xtera CommunicationsXtuitYard Yubico Yuga Labs ZaniaZeroZhone TechnologiesZiarcoZinc Platform Zingtree ZoomdataZosanoZumperZuoyebang株式会社プレイド

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 160

71 IPOs · 89 acquisitions · showing 69

Monte Rosa TherapeuticsNASDAQ: GLUEBuzzFeedNASDAQ: BZFDCourseraNYSE: COURCVRxNASDAQ: CVRXMirum PharmaceuticalsNASDAQ: MIRMNextNav HoldingsNASDAQ: NNNkarta, Inc.NASDAQ: NKTXOnkure Therapeutics IncNASDAQ: OKURRobinhoodNASDAQ: HOODSenti BiosciencesNASDAQ: SNTISprout SocialNASDAQ: SPTSpyglass PharmaNASDAQ: SGPSynlogicOTC: SYBXTempusNASDAQ: TEMTwilioNYSE: TWLOActelis NetworksOTC: ASNSAdaptimmuneOTC: ADAPYAddex TherapeuticsNASDAQ: ADXNAkari TherapeuticsNASDAQ: AKTXAmplitudeNASDAQ: AMPLBlack Diamond Therapeutics, IncNASDAQ: BDTXBloom EnergyNYSE: BEBoston ScientificNYSE: BSXBoxNYSE: BOXCelcuityNASDAQ: CELCChampions OncologyNASDAQ: CSBRCylanceNYSE: BBDuolingoNASDAQ: DUOLElasticNYSE: ESTCEnliven TherapeuticsNASDAQ: ELVNFiscal NoteOTC: NOTEForce10NYSE: DELLGeronNASDAQ: GERNGossamer BioNASDAQ: GOSSGroupon, Inc.NASDAQ: GRPNImaraNASDAQ: ELVNIridex CorporationNASDAQ: IRIXKorro BioNASDAQ: KRROLexicon PharmaceuticalsNASDAQ: LXRXLiquidia CorporationNASDAQ: LQDAMarker TherapeuticsNASDAQ: MRKRMirna TherapeuticsOTC: SYBXMongoDBNASDAQ: MDBNektar TherapeuticsNASDAQ: NKTRNeuroPaceNASDAQ: NPCENextnavNASDAQ: NNOmada HealthNASDAQ: OMDAOpendoorNASDAQ: OPENORIC PharmaceuticalsNASDAQ: ORICPagerDutyNYSE: PDPayPalNASDAQ: PYPLSagimet BiosciencesNASDAQ: SGMTSavaraNASDAQ: SVRASenseonicsNASDAQ: SENSSenseonics HoldingsNASDAQ: SENSSnapNYSE: SNAPSurf AirNYSE: SRFMTrevi TherapeuticsNASDAQ: TRVITuyaNYSE: TUYAUberNYSE: UBERUpstartNASDAQ: UPSTUpworkNASDAQ: UPWKVistaGen TherapeuticsNASDAQ: VTGNWorkdayNASDAQ: WDAYX4 PharmaNASDAQ: XFORXenon PharmaceuticalsNASDAQ: XENEZenas BiopharmaNASDAQ: ZBIOCatalyticacq. by PagerDutyCurzion Pharmaceuticals Incacq. by Horizon Therapeutics

Portfolio news

latest coverage across their companies

AI voice startup ElevenLabs doubles valuation to $22B

ElevenLabs · techcrunch.com · Sep 30, 2026

23andMe - Wikipedia

23andme · en.wikipedia.org · Sep 22, 2026

Coursera - Wikipedia

Coursera · en.wikipedia.org · Sep 22, 2026

Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboration with Roche, Aethlon Medical Merges with North Immunology | PharmExec

Orbis Medicines · pharmexec.com · Sep 17, 2026

Latitude Raises $35M Series A

Latitude · thesaasnews.com · Sep 11, 2026

PagerDuty - Wikipedia

PagerDuty · en.wikipedia.org · Sep 8, 2026

Courtyard.io Review 2026: Is It Legit & Worth It? | PackSpy

Courtyard.io · packspy.com · Sep 7, 2026

Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Black Diamond Therapeutics, Inc · finance.yahoo.com · Sep 2, 2026

Fund performance · per public LP disclosures · 19

as of Sep 2025

Fund	Vintage	Committed	Net IRR	TVPI	DPI
NEA SH 2025 SPVLPs: Orange County Employees Retirement System	2025	—	—	1.00x	—
NEA 18 VentureLPs: Los Angeles City Employees' Retirement System	2022	—	1.8%	1.03x	0.00x
NEA 18 Venture Growth EquityLPs: California State Teachers' Retirement System, Los Angeles City Employees' Retirement System, Orange County Employees Retirement System	2022	—	11.6%	1.20x	—
New Enterprise Associates 18LPs: Nebraska Investment Council, Los Angeles City Employees' Retirement System, California State Teachers' Retirement System +2 more	2022	—	40.5%	1.86x	0.11x
New Enterprise Associates 18rLPs: Orange County Employees Retirement System	2022	—	41.0%	2.00x	0.11x
New Enterprise Associates 17LPs: California State Teachers' Retirement System, Nebraska Investment Council, Los Angeles City Employees' Retirement System +2 more	2019	—	4.5%	1.17x	0.16x
New Enterprise Associates 16LPs: California State Teachers' Retirement System, Sacramento County Employees' Retirement System, Los Angeles City Employees' Retirement System +1 more	2017	—	8.2%	1.52x	0.42x
NEA 15 Opportunity Fund, L.P.LPs: North Carolina Retirement Systems, California State Teachers' Retirement System	2015	—	25.2%	3.68x	1.44x
NEA 15, L.P.LPs: North Carolina Retirement Systems	2015	—	11.3%	1.83x	1.03x
New Enterprise Associates 15LPs: California State Teachers' Retirement System, Sacramento County Employees' Retirement System, Los Angeles City Employees' Retirement System +2 more	2015	—	10.0%	1.75x	1.05x
NEA 14, L.P.LPs: North Carolina Retirement Systems	2012	—	14.9%	2.71x	1.14x
New Enterprise Associates 13LPs: California State Teachers' Retirement System, Nebraska Investment Council, New Mexico Public Employees Retirement Association +3 more	2008	—	—	2.76x	2.57x
New Enterprise Associates 12, L.P.LPs: California State Teachers' Retirement System, Washington State Investment Board, Pennsylvania Public School Employees' Retirement System +3 more	2006	—	6.4%	1.40x	1.39x
New Enterprise Associates 11LPs: California State Teachers' Retirement System, Pennsylvania Public School Employees' Retirement System, Hawaii Employees' Retirement System	2004	—	15.3%	2.65x	2.57x
New Enterprises Associates VIII A, L.P.LPs: California State Teachers' Retirement System	2001	—	-2.4%	0.79x	0.79x
New Enterprise Associates 10, L.P.LPs: California State Teachers' Retirement System, Washington State Investment Board, Pennsylvania Public School Employees' Retirement System +2 more	2000	—	2.3%	1.20x	1.13x
New Enterprise Associates 9, L.P.LPs: California State Teachers' Retirement System, Hawaii Employees' Retirement System, John S. and James L. Knight Foundation	1999	—	-6.1%	0.46x	0.46x
New Enterprises Associates VIII, L.P.LPs: California State Teachers' Retirement System	1998	—	30.6%	1.66x	1.64x
NEW ENTERPRISE ASSOCIATES 14, L.P.LPs: California State Teachers' Retirement System, New Mexico Public Employees Retirement Association, Hawaii Employees' Retirement System +3 more	—	—	—	3.31x	1.50x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

IPO stake values · per SEC filings · 14

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

Company	Owned	IPO price	At IPO	Stake value
Sprout Social	14.2%	$27.50	Aug 2020	$166.3M
Monte Rosa Therapeutics	15.0%	$19.00	Jun 2021	$126.4M
Spyglass Pharma	20.2%	$16.00	Feb 2026	$103.3M
Mirum Pharmaceuticals	16.5%	$20.00	Jan 2020	$83.7M
Senseonics Holdings	27.4%	$2.85	Mar 2016	$73M
Senseonics	27.4%	$2.85	Mar 2016	$73M
Onkure Therapeutics Inc	17.0%	$15.00	Apr 2021	$61.8M
Imara	21.4%	$16.00	Mar 2020	$56.7M
Enliven Therapeutics	21.4%	$16.00	Mar 2020	$56.7M
Black Diamond Therapeutics, Inc	7.7%	$19.00	Jan 2020	$50.3M
Trevi Therapeutics	27.7%	$10.00	May 2019	$49.3M
Zenas Biopharma	3.6%	$17.00	Sep 2024	$24.5M
Synlogic	14.8%	$7.00	Oct 2015	$20.8M
Champions Oncology	20.9%	$2.25	Jun 2016	$5.4M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has New Enterprise Associates (NEA) made?: New Enterprise Associates (NEA) has 1,155 tracked investments, 160 of which have exited, including 97 dated in the last 24 months.
What stage does New Enterprise Associates (NEA) invest at?: New Enterprise Associates (NEA) invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is New Enterprise Associates (NEA)'s typical check size?: New Enterprise Associates (NEA) typically writes checks of $200K – $40M.
What sectors does New Enterprise Associates (NEA) focus on?: New Enterprise Associates (NEA) focuses on AI & Machine Learning, Biotech, Consumer, Digital Health, Enterprise Software, Healthtech, Sector Agnostic.
Where is New Enterprise Associates (NEA) located?: New Enterprise Associates (NEA) is headquartered in Menlo Park, US.
Does New Enterprise Associates (NEA) lead rounds?: Yes, New Enterprise Associates (NEA) leads investment rounds.
Who does New Enterprise Associates (NEA) co-invest with?: New Enterprise Associates (NEA) most often shares deals with Andreessen Horowitz, Alumni Ventures, Kleiner Perkins, among 1,480 tracked co-investors.

Media · Podcasts & interviews

from their channel

AI for Science : Algorithms to Atoms

NEA VC

Building a Better Future – NEA Companies on a Mission

NEA VC

Optimatik & Forethought:Building Generative AI Companies In a Rapidly Evolving Market

NEA VC

Violet & Everside: Putting Patients First to Transform Care Delivery and Improve Outcomes

NEA VC

Thirteen Lune & Mejuri: Leaning Into Consumer Trends & Cultural Shifts to Build a Powerful D2C Brand

NEA VC

Flowbo & Patreon: Fueling the Creator Economy

NEA VC

Images

Co-investors · 402

Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.

$500K – $50M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

Both backed · 43

Bloom Energy Boston Scientific Box Coursera Duolingo Robinhood Sagimet Biosciences Snap Uber Upstart Aerohive Networks AlienVault Centralize Coda Cusp Ai CuspAI CV Therapeutics Databricks FabFitFun Feather Fizz Gloucester Pharmaceuticals HockeyStack Inkitt Juniper Networks Koala Mashgin Nimble Storage Plaid Quill Sapho Segment Swiftype Synthesia Tesaro Together AI ZumperAnywhereAscend CommunicationsEvalveSeragon PharmaceuticalsSilicon SpiceVertica

$500K – $15M

Accel

Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.

Both backed · 39

$1.6M – $70M

Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

Both backed · 38

$100K – $10M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M

SV Angel

SV Angel is a San Francisco-based firm that invests long-term in founders, supporting them with advice, introductions, and network access at key business inflection points.

$150K – $20M

Sequoia Capital

Sequoia Capital is a venture capital firm that partners with founders to build technology companies.

$4.4M – $214M

Khosla Ventures

Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.

Both backed · 34

$5K – $50M

NewView Capital

NewView Capital is a growth-stage investment firm providing flexible capital to high-potential companies in enterprise software and fintech, supporting them with operational guidance and network connections.

Norwest Venture Partners

Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.

$10M – $30M

General Catalyst

General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.

$30M

Menlo Ventures

Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.

Both backed · 28

Senti Biosciences Uber Upstart Upwork Aeluros Clarifai CV Therapeutics Flow Forerunner Heap Indio Nimble Storage Node Pluribus Networks Qualified Health Rf Surgical Sana Labs Save Scout RFP Singularity Slash Tintri Wispr Flow Xaira TherapeuticsAscend CommunicationsCarrier Access CorporationCyras SystemsUUNET

$1M – $20M

▶390 more co-investors

Lightspeed Venture Partners Index Ventures Insight Partners Benchmark Felicis Ventures Greylock Partners Notable Capital Battery Ventures Bessemer Venture Partners First Round Capital IVP (Institutional Venture Partners)SoftBank Vision Fund Foundation Capital Greycroft Lux Capital Techstars Salesforce Ventures OrbiMed Coatue Management Tiger Global Management F-Prime Capital Soma Capital Sofinnova Ventures Redpoint Ventures BoxGroup 8VC Intel Capital RA Capital Aisling Capital Lightstone Ventures Madrona Venture Group Comcast Ventures Versant Ventures Foresite Capital Evolution VC Partners Canaan Partners Sapphire Ventures Venrock Pfizer Venture Investments Founders Fund Craft Ventures Bain Capital Ventures Lerer Hippeau CapitalG Cisco Investments Founder Collective Union Square Ventures (USV)Meritech Capital Partners Runa Capital RiverVest Venture Partners Gradient Ventures Liquid Ventures Thrive Capital Flare Capital Partners SR One Capital Management Sanofi Ventures Vensana Capital Great Oaks Venture Capital RRE Ventures Oak HC/FT SignalFire Canvas Ventures Bond Capital Management Goodwater Capital General Atlantic Qualcomm Ventures Slow Ventures Matrix Tenaya Capital Storm Ventures Owl Ventures Abingworth CRV (Charles River Ventures)Streamlined Ventures Innovation Endeavors Emergence Capital Partners Wing Tuesday Capital ARCH Venture Partners Third Point Ventures Collaborative Fund Artis Ventures OUP (Osage University Partners)Deerfield Management Company Frazier Healthcare Partners Nextech Invest Pappas Capital Spark Capital DST Global Balderton Capital ACME Capital Forerunner Ventures Flybridge Capital Partners Cota Capital Bonfire Ventures Sierra Ventures Maveron Atlas Venture Sherpalo Ventures Northzone Speedinvest Dreamers VC MaC Venture Capital Basis Set Ventures 137 Ventures Radical Ventures AI Fund MVP Ventures Ascension Ventures Workday Ventures Clarus Ventures Susa Ventures Acrew Capital Pear VC Winklevoss Capital Pelion Venture Partners AlleyCorp August Capital Crosscut Ventures Construct Capital 5AM Ventures Granite Asia Energize Capital Green Bay Ventures TriplePoint Capital Quadrille Capital Red & Blue Ventures Long Journey Ventures B Capital Group Eniac Ventures AME Cloud Ventures Obvious Ventures Ribbit Capital Hack VC AIX Ventures Draper Fisher Jurvetson (DFJ)Spider Capital Unpopular Ventures HOF Capital Multicoin Capital Endeavor Catalyst GE Ventures Miramar Venture Partners Learn Capital venBio Partners The Column Group Morgenthaler Rethink Capital Partners Ysios Capital Roche Venture Fund Tensility Venture Partners True Ventures FirstMark Capital Bling Capital Accel-KKR Addition PICUS CAPITAL Bowery Capital Ridge Ventures DCM Ventures Kortschak Investments L.P.EQT Ventures Gaingels Cowboy Ventures Standard Capital HV Capital Ballistic Ventures Webb Investment Network Lakestar Javelin Venture Partners Breakthrough Energy Ventures FELIX CAPITAL Giant Ventures Global Llp Walden International H.I.G. Growth Partners Alpaca VC Cervin Novartis Venture Fund GSV Ventures Omega Funds Velvet Sea Ventures Samsung Ventures Uncork Capital SOSV SciFi VC Kapor Capital IA Ventures Trinity Ventures 01 Advisors Paradigm Social Leverage Harrison Metal Global Founders Capital Chemistry The Chernin Group (TCG Crypto)Next Play Ventures Left Lane Capital Energy Impact Partners Transmedia Capital Decibel Partners Valar Ventures Llc Coelius Capital Ff Venture Capital Formation Group MMC Ventures White Star Capital 9Yards Capital Future Perfect Ventures Scrum Ventures Alven BlueRun Ventures Greenoaks Silverton Partners Ensemble VC Pitango Think+ Ventures Management, Llc Root Ventures Manager, Llc Race Capital Amity Ventures Sutter Hill Ventures JAZZ Venture Partners Paladin Capital Group TMV Prelude Ventures EQT Life Sciences Northpond Ventures Neotribe Ventures Dimension Capital Jump Capital Illuminate Ventures Moderne Ventures Cultivation Capital Forbion Cerity Partners Ventures Xplorer Capital Slack Fund Domain Associates SparkLabs Global Ventures LiveOak Ventures Stanford University Cavalry Ventures Big Idea Ventures Imaginary Venture Capital Elephant Partners Harpoon Ventures CVS Health Ventures Mercury Fund JDRF T1D Fund Cosmic Venture Partners Everywhere Ventures Quiet Capital Offline Ventures Freestyle Capital Afore Capital Hanabi Capital Accomplice Shasta Ventures Costanoa Ventures Eclipse Ventures MS&AD Ventures 23andMe ICONIQ Capital Viola Ventures OMERS Ventures Mosaic Ventures Prefix Capital Preston-Werner Ventures Team8 StageOne Ventures Helium-3 Ventures Jetstream Amasia Fusion Voyager Capital Highbury Holdings Amplo Ventures Signia Venture Partners Primitive Ventures BINARY CAPITAL Moonfire Ventures WestCap Arrive AV8 Ventures Atlantic Bridge Ventures redalpine Tola Capital Elaia MizMaa Ventures 7wire Ventures Listen Ventures Arboretum Ventures OCA Ventures Roosh Ventures Arthur Ventures Max Ventures Arbor Ventures Core Innovation Capital Optum Ventures Celonis Morpheus Ventures Inkef Ansa Capital Vida Ventures NTT Venture Capital Core Venture Capital 17Sigma humbition Agent Capital BCF Ventures 4BIO Capital Geekdom Lam Capital Okapi Venture Capital HBM Partners Sante Ventures M-One Capital Mohr Davidow Ventures Sancus Ventures Able Partners Unknown Ventures Uber Kraken Goat Capital NextView Ventures HCVC Stellar Capital Stride VC Trajectory Ventures Catapult Capital Not Boring Capital QueensBridge Venture Partners Tq Ventures Llc WGI Group Betaworks Ventures Management, Llc Digital Currency Group Hyde Park Venture Partners Company Capital 2xN Polychain Capital American Express Ventures (Amex)The Finger Group Kohlberg Kravis Roberts Allison Pickens Ventures xfactor ventures La Famiglia K2 Global UP Partners Presight Capital Active Capital Next Coast Ventures Euclid Venture Partners WestWave Capital FYRFLY Venture Partners Gutbrain Ventures BootstrapLabs S Capital Walden Catalyst f7 Ventures Builders VC Ligature VC Mysten Labs Redpoint eventures Metamorphic Ventures Prime Movers Lab Bain Capital Venture Patron Marathon Venture Capital Zintinus Amara VC Energy Capital Ventures Makers Camp Maverick Capital Leadout Capital Matter Venture Partners StarVest Partners Chainforest America's Frontier Fund Collide Capital OpenCapital.vc Upheaval Investments Wealthing VC Club Planeteer Capital Turing Capital Voyager Partners Florida Funders Outliers VC 82VS Emmeline Ventures Nest.Bio Ventures Single Fin Ventures

Firms observed investing alongside New Enterprise Associates (NEA), from public investor directories. Shared companies are the overlap with New Enterprise Associates (NEA)'s recorded portfolio.

Similar investors

8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$100K – $50M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

$5M – $100M

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

$5M – $30M

GV (Google Ventures)

$250K – $50M